Trochanteric bursitis

M13_TROCHANTERICBURSITIS

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — M70.6 Hospital discharge: ICD-9 — 7265A Cause of death: ICD-10 — M70.6 Cause of death: ICD-9 — 7265A 2 out of 7 registries used, show all original rules.	6481
4. Check minimum number of events None	6481
5. Include endpoints None	6481
6. Filter based on genotype QC (FinnGen only)	6286

Control definitions (FinnGen only)

Control exclude: M13_SOFTTISSUE

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: M70
Name in latin: Bursitis trochanterica

NAME	M13_TROCHANTERICBURSITIS
CONTROL_EXCLUDE	M13_SOFTTISSUE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	M706
HD_ICD_9	7265A
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	M706
COD_ICD_9	7265A
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Trochanteric bursitis based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	30347	24940	5300
Only index persons	29148	24158	4990
Unadjusted period prevalence (%)
Whole population	0.61	0.71	0.15
Only index persons	0.77	0.89	0.19
Median age at first event (years)
Whole population	61.31	61.11	62.38
Only index persons	60.92	60.71	61.95

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	6286	5269	1017
Unadjusted period prevalence (%)	1.64	1.87	0.47
Median age at first event (years)	61.04	60.23	65.21

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
6481: Matched controls
64810

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

TNX00, ,

SPAT

15.8

321.8

280

185

M01AH01

ATC

celecoxib; oral

3.1

321.5

1699

6595

L17

ICPC

Foot/toe symptom/complaint

2.8

318.8

2401

11293

NDM40

NOMESCO Finland

Discission of sheath of tendon of wrist or hand

46.7

317.3

186

M01AB05

ATC

diclofenac; systemic, rectal

3.0

316.1

4884

32797

NBG15

NOMESCO Finland

Acromioplastia, arthroscopic

28.2

307.7

564

218

M01AH05

ATC

etoricoxib; oral

4.2

307.7

5067

29846

M79.7

ICD-10 Finland

Fibromyalgia

16.3

307.7

515

342

M03BX02

ATC

tizanidine; oral

3.2

307.7

4772

30407

M19.0

ICD-10 Finland

Primary arthrosis of other joints

4.5

307.7

1003

2515

M79.0

ICD-10 Finland

Rheumatism, unspecified

48.9

307.7

551

123

N03AX12

ATC

[U] gabapentin; oral

6.1

307.7

2064

4600

N06AX21

ATC

duloxetine; oral

5.4

307.7

1445

3261

M70.6

ICD-10 Finland

Trochanteric bursitis

1664.5

307.7

6427

4325

M25.5

ICD-10 Finland

Pain in joint

4.5

307.7

3304

12270

M79.1

ICD-10 Finland

Myalgia

4.2

307.7

1337

3750

N03AX16

ATC

[U] pregabalin

5.3

307.7

2722

7828

M01AC06

ATC

meloxicam; systemic, rectal

2.7

307.7

3074

16237

N06AA09

ATC

amitriptyline; systemic

4.2

307.7

1024

2798

M79.6

ICD-10 Finland

Pain in limb

6.0

307.7

4066

14223

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

3.2

307.7

3632

18418

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.9

307.7

3006

14991

M54.5

ICD-10 Finland

Low back pain

4.5

307.7

3593

14149

M54.4

ICD-10 Finland

Lumbago with sciatica

5.7

307.7

2292

5637

N02AX02

ATC

tramadol; systemic, rectal

4.4

307.7

3901

16705

M54.9

ICD-10 Finland

Dorsalgia, unspecified

4.0

307.7

1208

3526

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

5.3

307.7

1702

4048

L13

ICPC

Hip symptom/complaint

5.6

307.7

2660

7179

M03BC01

ATC

orphenadrine (citrate); systemic

3.1

307.7

1982

8084

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

6.8

307.7

1137

1963

M70.7

ICD-10 Finland

Other bursitis of hip

10.1

307.7

526

563

L03

ICPC

Low back symptom/complaint

3.4

307.7

2611

10824

NE1BG

NOMESCO Finland

Pelvic, hip and femur MRI examination with high intensity magnet

13.2

307.7

585

482

M76.0

ICD-10 Finland

Gluteal tendinitis

15.6

307.7

456

313

L08

ICPC

Shoulder symptom/complaint

3.1

307.7

1849

7457

NE1CG

NOMESCO Finland

Pelvic, hip and femur extensive MRI examination with high intensity magnet

11.1

307.7

398

379

M75.1

ICD-10 Finland

Rotator cuff syndrome

5.9

307.7

2408

5932

N02BF01

ATC

gabapentin; oral

5.2

307.7

931

2011

N02AJ06

ATC

codeine and paracetamol; systemic

3.3

307.7

3502

16964

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

13.3

307.7

664

552

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

4.8

307.7

1109

2672

M48.0

ICD-10 Finland

Spinal stenosis

5.2

307.7

1472

3452

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

5.5

307.7

1716

4002

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

6.1

307.7

760

1391

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

7.2

307.7

1436

2451

A02BC05

ATC

esomeprazole; systemic

2.6

305.2

3307

18515

R51.80

ICD-10 Finland

Headache

3.4

303.6

1345

4684

R52.9

ICD-10 Finland

Pain, unspecified

4.0

299.6

980

2793

M54.3

ICD-10 Finland

Sciatica

5.0

299.1

694

1517

A02BC02

ATC

pantoprazole; systemic

3.0

295.6

5079

35395

G44.2

ICD-10 Finland

Tension-type headache

3.3

293.2

1307

4561

M16.1

ICD-10 Finland

Other primary coxarthrosis

3.4

290.6

1231

4161

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

2.8

278.1

1941

8678

A01

ICPC

Pain general/multiple sites

3.9

276.5

913

2612

NF1AA

NOMESCO Finland

Hip X-ray examination

3.8

273.8

938

2752

A02BC03

ATC

lansoprazole; oral

2.6

272.6

2371

11802

NFM20

NOMESCO Finland

Excision of bursa of hip or thigh

2599.9

270.5

260

M77.1

ICD-10 Finland

Lateral epicondylitis

4.8

268.6

658

1501

R10.1

ICD-10 Finland

Pain localized to upper abdomen

2.9

262.0

1561

6398

H02AB06

ATC

prednisolone; systemic

2.4

255.8

3532

21524

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

6.2

255.3

458

790

M17.1

ICD-10 Finland

Other primary gonarthrosis

2.7

251.4

1839

8358

R07.4

ICD-10 Finland

Chest pain, unspecified

2.5

250.7

2188

10827

G56.0

ICD-10 Finland

Carpal tunnel syndrome

3.2

250.0

1170

4175

M02AA07

ATC

piroxicam; topical

2.4

248.1

2844

15909

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.5

247.0

2298

11699

R03AC02

ATC

salbutamol; inhalant

2.4

243.2

4025

26321

M01AH02

ATC

rofecoxib; oral

3.1

240.2

1161

4215

N02BF02

ATC

pregabalin; oral

4.6

239.1

604

1409

M01AE02

ATC

naproxen; oral, rectal

2.4

239.0

4038

26558

M76.8

ICD-10 Finland

Other enthesopathies of lower limb, excluding foot

11.5

238.8

251

227

M16.9

ICD-10 Finland

Coxarthrosis, unspecified

4.2

236.2

683

1768

M54.1

ICD-10 Finland

Radiculopathy

5.9

236.1

445

804

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

4.2

235.6

672

1722

M54.2

ICD-10 Finland

Cervicalgia

4.0

233.5

729

1995

L28

ICPC

Limited function/disability (L)

2.7

230.2

1510

6461

NBG10

NOMESCO Finland

Acromioplastia

24.6

230.1

163

N02BE01

ATC

paracetamol; systemic, rectal

6.0

228.9

6208

51280

ABC36

NOMESCO Finland

Decompression of lumbar nerve roots

4.9

227.5

531

1160

R52.2

ICD-10 Finland

Other chronic pain

6.2

226.3

403

689

M47.82

ICD-10 Finland

Other spondylosis, cervical region

5.5

224.9

457

885

R06.0

ICD-10 Finland

Dyspnoea

2.4

223.0

2063

10389

J01.0

ICD-10 Finland

Acute maxillary sinusitis

2.5

220.8

1924

9422

NBA30

NOMESCO Finland

Exploration of joint of shoulder or upper arm, arthroscopic

16.2

220.5

188

119

NE1AA

NOMESCO Finland

Pelvis X-ray examination

3.8

220.0

738

2121

M75.0

ICD-10 Finland

Adhesive capsulitis of shoulder

5.7

218.5

426

794

A02BC01

ATC

omeprazole; systemic

2.4

218.0

2139

11039

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

11.7

217.9

225

198

M53.1

ICD-10 Finland

Cervicobrachial syndrome

3.2

215.7

996

3506

ZXA00

NOMESCO Finland

Right side

2.4

215.6

2052

10438

M03BC51

ATC

orphenadrine, combinations; systemic

2.4

214.6

2149

11176

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

5.1

214.2

474

989

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

3.0

213.4

1071

3954

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

5.8

212.7

405

738

M01AX17

ATC

nimesulide; oral

2.4

208.3

1898

9446

M77.4

ICD-10 Finland

Metatarsalgia

4.5

199.2

520

1241

S46.0

ICD-10 Finland

Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder

4.0

198.7

615

1667

L86

ICPC

Back syndrome with radiating pain

4.0

198.4

603

1613

M01AE03

ATC

ketoprofen; systemic, rectal

2.2

197.0

2687

15769

UJF32

NOMESCO Finland

Coloscopy

2.3

196.8

2041

10705

M47.9

ICD-10 Finland

Spondylosis, unspecified

6.0

196.6

357

621

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

2.3

194.6

2187

11853

M72.2

ICD-10 Finland

Plantar fascial fibromatosis

3.6

193.9

703

2122

J45.9

ICD-10 Finland

Asthma, unspecified

2.5

189.1

1508

7021

S18

ICPC

Laceration/cut

2.1

184.7

3166

20150

L15

ICPC

Knee symptom/complaint

2.3

183.9

1870

9680

A06AC01

ATC

ispaghula (psylla seeds); oral

2.2

183.6

2114

11521

R42

ICD-10 Finland

Dizziness and giddiness

2.3

182.1

1791

9134

N06AX16

ATC

venlafaxine; oral

2.7

182.0

1143

4732

Z01.8

ICD-10 Finland

Other specified special examinations

2.4

181.6

1710

8558

M54.6

ICD-10 Finland

Pain in thoracic spine

3.6

181.6

654

1963

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

5.8

179.1

337

606

ZXA05

NOMESCO Finland

Left side

2.3

178.3

1868

9771

R4110

NOMESCO Finland

Physiotherapy

2.2

178.3

2096

11493

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

4.9

178.2

414

898

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

2.1

176.6

3200

20680

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

3.3

176.4

732

2402

M43.1

ICD-10 Finland

Spondylolisthesis

4.6

175.8

440

1014

N06AX11

ATC

mirtazapine; oral

2.1

175.6

2538

15066

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

3.1

175.5

837

2983

NBL00

NOMESCO Finland

Suture or reinsertation of rotator cuff of shoulder

6.0

175.1

316

546

Z3226

NOMESCO Finland

Physiotherapist

2.5

174.8

1400

6506

NB1BG

NOMESCO Finland

Shoulder and humerus MRI examination with high intensity magnet

12.8

173.8

169

135

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.4

170.7

1411

6644

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

3.5

170.3

640

1972

M16.0

ICD-10 Finland

Primary coxarthrosis, bilateral

3.3

170.2

691

2236

X59

ICD-10 Finland

Exposure to unspecified factor

2.5

169.9

1315

6007

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

3.7

169.4

577

1666

A02BA02

ATC

ranitidine; systemic

2.4

167.9

1483

7186

M54

ICD-10 Finland

Dorsalgia

2.8

166.6

981

3916

M01AB55

ATC

diclofenac, combinations; oral

3.5

165.0

609

1854

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

6.4

164.2

280

457

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

8.4

164.2

217

267

M67.4

ICD-10 Finland

Ganglion

4.4

161.3

427

1027

J01DB01

ATC

cefalexin; oral

2.6

160.8

5514

44698

M01AX05

ATC

glucosamine; oral

2.3

159.1

1604

8201

R01AD09

ATC

mometasone; nasal

2.0

158.8

3192

21140

NBG00

NOMESCO Finland

Plastic operation on acromioclavicular joint

21.4

158.0

118

L12

ICPC

Hand/finger symptom/complaint

2.5

157.6

1184

5318

M02AA10

ATC

ketoprofen; topical

2.4

157.0

1271

5907

J01AA02

ATC

doxycycline; systemic

2.4

156.8

5363

43090

Z71.8

ICD-10 Finland

Other specified counselling

2.1

156.4

2201

12811

N06CA01

ATC

amitriptyline and psycholeptics; systemic

2.8

153.7

895

3544

G54.0

ICD-10 Finland

Brachial plexus disorders

7.0

153.3

238

352

NDM20

NOMESCO Finland

Excision of synovial ganglion of wrist or hand

24.4

152.3

108

M35.7

ICD-10 Finland

Hypermobility syndrome

11.1

152.1

162

149

M65.3

ICD-10 Finland

Trigger finger

5.7

150.7

290

532

L01

ICPC

Neck symptom/complaint

2.4

149.1

1189

5476

NBT60

NOMESCO Finland

Forcible manipulation of humeroscapular joint

26.1

149.0

103

NB1CG

NOMESCO Finland

Shoulder and humerus extensive MRI examination with high intensity magnet

11.3

148.2

156

141

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.0

148.0

3068

20371

R03DC03

ATC

montelukast; oral

2.3

144.5

1292

6250

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

2.4

143.6

1148

5285

NBF25

NOMESCO Finland

Operation for humeroscapular osteochondritis, arthroscopic

12.3

143.3

143

119

L02

ICPC

Back symptom/complaint

2.8

141.7

792

3063

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

2.2

141.6

1450

7417

WX110

NOMESCO Finland

Infiltration anesthesia

2.1

141.4

4676

36152

R53

ICD-10 Finland

Malaise and fatigue

2.1

141.4

1676

9083

R05

ICPC

Cough

2.1

141.0

1766

9772

SPAT1212

SPAT

Extensive examination of musculoskeletal system

3.1

140.1

649

2263

R07.3

ICD-10 Finland

Other chest pain

2.8

138.9

786

3058

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

2.8

138.6

804

3168

P01AB01

ATC

metronidazole; oral, rectal

1.9

138.6

2928

19431

J01FA06

ATC

roxithromycin; oral

1.9

138.4

2811

18411

TNX00

NOMESCO Finland

Puncture and needle biopsy of soft tissue, unspecified region

7.3

137.5

205

290

H02BX01

ATC

methylprednisolone, combinations; systemic

3.7

136.3

459

1311

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

2.7

134.6

819

3304

NBL22

NOMESCO Finland

Myotomy, tenotomy or excision of tendon of upper arm

17.9

134.6

109

N05CF01

ATC

zopiclone; oral

2.0

133.7

2316

14339

J02AC01

ATC

fluconazole; systemic

1.9

133.2

3075

20918

J01MA02

ATC

ciprofloxacin; systemic

1.9

133.1

2572

16510

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.3

133.1

1203

5827

N01

ICPC

Headache

2.8

132.9

762

2981

J01FA10

ATC

azithromycin; systemic

1.9

132.6

3870

28369

R60.0

ICD-10 Finland

Localized oedema

2.5

132.3

922

3973

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.9

132.2

2744

18021

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

2.0

130.6

2119

12808

H02AB04

ATC

methylprednisolone; systemic

2.3

130.1

1121

5315

D01

ICPC

Abdominal pain/cramps general

2.6

130.0

893

3821

NB1AE

NOMESCO Finland

Shoulder ultrasound examination

8.3

127.3

168

206

M75.3

ICD-10 Finland

Calcific tendinitis of shoulder

8.5

127.3

165

198

R05

ICD-10 Finland

Cough

2.1

126.7

1574

8634

G57.1

ICD-10 Finland

Meralgia paraesthetica

7.2

126.4

189

268

G47.3

ICD-10 Finland

Sleep apnoea

2.2

125.5

1392

7309

M54.8

ICD-10 Finland

Other dorsalgia

3.8

125.5

398

1090

M53.0

ICD-10 Finland

Cervicocranial syndrome

2.7

125.4

729

2869

ABC56

NOMESCO Finland

Decompression of lumbar spinal canal and nerve roots

5.2

124.4

262

521

K30

ICD-10 Finland

Functional dyspepsia

2.5

124.2

891

3886

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

2.4

124.0

998

4585

WX002

NOMESCO Finland

Sedation and analgesia

2.1

123.4

1421

7565

R02

ICPC

Shortness of breath/dyspnoea

2.4

123.0

971

4423

SAA01

NOMESCO Finland

Simple examination of mouth

1.9

122.3

4643

36587

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

2.4

121.9

977

4479

R06AE07

ATC

cetirizine; oral

1.8

121.0

3072

21317

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

2.8

120.7

657

2496

X58

ICD-10 Finland

Exposure to other specified factors

2.5

120.3

888

3921

WX320

NOMESCO Finland

Spinalanesthesy

2.0

120.3

1682

9605

WZA90

NOMESCO Finland

Other medical or dental certificate

2.0

118.3

1585

8906

N02AJ13

ATC

tramadol and paracetamol; systemic

5.6

117.7

226

413

M16

ICD-10 Finland

Coxarthrosis [arthrosis of hip]

3.3

117.7

474

1516

NBL05

NOMESCO Finland

Arthroscopic suture or reinsertation of rotator cuff of shoulder

14.5

117.7

106

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.9

116.7

1952

11832

E66.01

ICD-10 Finland

Obesity due to excess calories

2.8

116.7

654

2522

K59.09

ICD-10 Finland

Constipation, unspecified

3.1

116.3

532

1835

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.8

115.1

3047

21306

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.8

114.9

3601

26472

R52.1

ICD-10 Finland

Chronic intractable pain

11.5

114.8

119

105

N02AA05

ATC

oxycodone; systemic

2.2

114.6

1211

6216

SPAT1203

SPAT

Injection therapy, other than intramuscular or subcutaneous

3.8

114.0

365

1005

J01FF01

ATC

clindamycin; systemic

1.9

114.0

1798

10672

M47.80

ICD-10 Finland

Other spondylosis, multiple sites in spine

4.8

113.8

260

554

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

2.2

113.4

1150

5805

R74

ICPC

Upper respiratory infection acute

1.9

113.1

2013

12430

NAG62

NOMESCO Finland

Posterior fusion of lumbar spine with fixation, 2-3 vertebraea

5.6

112.4

216

395

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

4.8

112.1

261

565

M13.9

ICD-10 Finland

Arthritis, unspecified

3.0

111.5

541

1929

L16

ICPC

Ankle symptom/complaint

2.5

111.3

809

3539

Z01.2

ICD-10 Finland

Dental examination

1.8

110.7

2996

21003

J01EA01

ATC

trimethoprim; systemic

1.9

110.4

2053

12836

R5599

NOMESCO Finland

Other rehabilitation service

4.8

110.2

254

545

M77.9

ICD-10 Finland

Enthesopathy, unspecified

4.8

110.2

255

549

J01DA01

ATC

[U] cefalexin

1.8

110.1

4035

30902

J01FA09

ATC

clarithromycin; systemic

1.9

109.9

2151

13664

Z76.0

ICD-10 Finland

Issue of repeat prescription

2.0

109.8

1597

9202

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

2.7

109.6

668

2685

L87

ICPC

Bursitis/tendinitis/synovitis NOS

6.6

109.6

179

279

M23.2

ICD-10 Finland

Derangement of meniscus due to old tear or injury

2.5

109.4

759

3249

ZXE10

NOMESCO Finland

More than one and less than three hours

1.8

109.3

2432

16065

M75.9

ICD-10 Finland

Shoulder lesion, unspecified

3.6

108.5

376

1092

ACC51

NOMESCO Finland

Release of median nerve

2.9

107.9

558

2059

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

3.0

107.9

522

1857

R01BA52

ATC

pseudoephedrine, combinations; oral

1.8

107.1

2205

14204

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

2.0

107.0

1342

7329

R03BA02

ATC

budesonide; inhalant

2.1

106.9

1285

6910

N06AA10

ATC

nortriptyline; systemic

5.7

106.8

202

364

M01AC01

ATC

piroxicam; systemic, rectal

2.3

106.7

979

4737

L14

ICPC

Leg/thigh symptom/complaint

2.8

106.6

592

2268

M01AX01

ATC

nabumetone; oral

3.6

106.6

369

1071

M01AE01

ATC

ibuprofen; systemic, rectal

2.5

106.5

5873

51331

M01AB08

ATC

etodolac; oral

2.8

106.4

574

2166

B01AB05

ATC

enoxaparin; parenteral

1.8

106.0

2186

14081

AA1AD

NOMESCO Finland

CT of head and brain

1.9

105.7

1770

10672

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.8

105.7

3188

22959

J45.0

ICD-10 Finland

Predominantly allergic asthma

2.7

105.7

644

2587

S29

ICPC

Skin symptom/complaint other

2.0

105.6

1355

7457

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

4.4

105.3

269

627

N04BC05

ATC

pramipexole; oral

2.7

105.0

601

2338

R01AD08

ATC

fluticasone; nasal

1.9

104.9

1939

12062

H01

ICPC

Ear pain/earache

2.4

104.9

814

3663

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

2.0

104.8

1458

8256

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.4

104.6

850

3904

M75.5

ICD-10 Finland

Bursitis of shoulder

5.5

104.4

206

386

SAA02

NOMESCO Finland

Basic examination of mouth

1.8

104.2

4212

32937

M76.6

ICD-10 Finland

Achilles tendinitis

3.9

104.1

316

838

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

3.1

103.6

462

1568

M51.8

ICD-10 Finland

Other specified intervertebral disc disorders

7.8

103.1

143

186

N39.4

ICD-10 Finland

Other specified urinary incontinence

2.4

102.8

814

3694

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.8

102.8

3308

24194

J45

ICD-10 Finland

Asthma

2.4

102.8

804

3629

L04AX03

ATC

methotrexate; systemic

2.5

102.6

734

3182

R03BA05

ATC

fluticasone; inhalant

2.1

102.6

1261

6826

R03AK07

ATC

formoterol and budesonide; inhalant

2.0

102.3

1434

8132

M50.3

ICD-10 Finland

Other cervical disc degeneration

5.1

102.0

217

435

NFM10

NOMESCO Finland

Fasciotomy of thigh

49.6

101.8

R96

ICPC

Asthma

2.5

101.5

742

3248

K07.60

ICD-10 Finland

Snapping jaw

3.3

101.4

399

1256

G04BD12

ATC

mirabegron; oral

2.3

100.6

893

4254

P01BA02

ATC

hydroxychloroquine; oral

2.5

99.9

670

2816

M70.8

ICD-10 Finland

Other soft tissue disorders related to use, overuse and pressure

11.1

99.8

106

M76.3

ICD-10 Finland

Iliotibial band syndrome

13.7

98.9

ACC59

NOMESCO Finland

Decompression and freeing of adhesions of peripheral nerve: other or unspecified

3.5

98.7

350

1031

A02BC04

ATC

rabeprazole; oral

2.5

98.5

659

2766

C07AB07

ATC

bisoprolol; oral

1.7

98.0

3137

22798

M17

ICD-10 Finland

Gonarthrosis [arthrosis of knee]

2.3

98.0

884

4237

R06AX27

ATC

desloratadine; oral

1.8

97.8

1909

12029

L29

ICPC

Musculoskeletal sympt/complt other

2.6

97.6

645

2692

D06

ICPC

Abdominal pain localized other

2.5

97.5

663

2804

SFA10

NOMESCO Finland

One-surface restoration

1.7

97.2

3467

25934

G55.1*M51.1

ICD-10 Finland

Compression of nerve roots and nerve plexus in disc diseases in the lumbar region and other regions

4.6

96.8

234

522

NG1BG

NOMESCO Finland

Knee and lower leg MRI examination with high intensity magnet

4.0

96.7

282

726

R4120

NOMESCO Finland

Occupational therapy

2.9

96.7

470

1674

SPAT1153

SPAT

Removal of sutures

1.8

96.6

2034

13104

R03AC03

ATC

terbutaline; inhalant

2.1

96.3

1017

5189

R52.0

ICD-10 Finland

Acute pain

4.1

96.2

273

689

R01AD58

ATC

fluticasone, combinations; nasal

1.9

96.1

1589

9496

N30.0

ICD-10 Finland

Acute cystitis

2.0

95.8

1287

7171

NA6BG

NOMESCO Finland

Sacro-iliac joint MRI examination with high intensity magnet

7.1

95.5

144

206

D11

ICPC

Diarrhoea

2.3

95.4

791

3656

ZXD10

NOMESCO Finland

Scheduled procedure

1.7

95.3

2561

17688

H04.10

ICD-10 Finland

Dry eye syndrome

2.2

95.2

899

4387

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

2.0

95.0

1207

6593

S80.0

ICD-10 Finland

Contusion of knee

2.7

94.6

542

2107

NAG40

NOMESCO Finland

Anterior fusion of cervical spine without fixation

5.5

94.5

185

344

N03AE01

ATC

clonazepam; systemic

3.0

94.3

431

1482

J01CA04

ATC

amoxicillin; systemic

1.9

93.9

5247

44459

G56.2

ICD-10 Finland

Lesion of ulnar nerve

4.6

93.5

229

516

M01AH03

ATC

valdecoxib; oral

2.9

93.0

460

1653

M75.2

ICD-10 Finland

Bicipital tendinitis

5.5

92.8

182

339

M15.0

ICD-10 Finland

Primary generalized (osteo)arthrosis

3.9

92.8

282

748

C03CA01

ATC

furosemide; systemic

1.8

92.7

1845

11662

NB2AT

NOMESCO Finland

Intra artrial injection of shoulder with ultrasound guidance

10.0

92.6

106

108

UKC02

NOMESCO Finland

Cystoscopy

2.2

92.1

892

4393

WX408

NOMESCO Finland

General anesthesy, balanced

1.8

92.0

1665

10218

SFA20

NOMESCO Finland

Two-surface restoration

1.7

90.7

3681

28290

M76.9

ICD-10 Finland

Enthesopathy of lower limb, unspecified

8.3

90.6

119

145

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.1

90.5

1055

5576

ABD30

NOMESCO Finland

Implantation of spinal stimulation device

12.2

90.0

M77.0

ICD-10 Finland

Medial epicondylitis

5.2

89.8

186

364

NJ2MA

NOMESCO Finland

Measurement of mechanical axis of lower leg with X-ray

2.7

89.7

526

2067

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.3

89.4

727

3328

NGA30

NOMESCO Finland

Exploration of knee joint, arthroscopic

3.3

89.3

358

1139

ZXD20

NOMESCO Finland

Day surgery

2.2

89.1

902

4517

K02.1

ICD-10 Finland

Caries of dentine

1.7

89.0

3595

27532

N05BA01

ATC

diazepam; systemic, rectal

2.1

89.0

912

4589

R21

ICPC

Throat symptom/complaint

2.0

88.8

1260

7135

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

2.6

88.6

565

2314

A03FA02

ATC

cisapride; oral, rectal

2.6

88.4

576

2383

M15

ICD-10 Finland

Polyarthrosis

2.9

88.0

450

1646

A11

ICPC

Chest pain NOS

2.5

87.9

588

2464

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

2.2

87.6

799

3837

R01AD12

ATC

fluticasone furoate; nasal

1.8

87.4

2004

13157

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

2.5

87.3

607

2589

M19.9

ICD-10 Finland

Arthrosis, unspecified

3.2

86.7

352

1128

Z3231

NOMESCO Finland

Registered nurse

1.8

86.7

1749

11061

NGD05

NOMESCO Finland

Partial excision of meniscus of knee, arthroscopic

2.3

86.5

709

3255

H57.1

ICD-10 Finland

Ocular pain

3.6

86.2

291

829

R03BA01

ATC

beclometasone; inhalant

2.1

86.2

1005

5306

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

5.0

86.1

189

389

M75.8

ICD-10 Finland

Other shoulder lesions

3.8

86.1

267

718

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

2.4

86.0

655

2912

XA402

NOMESCO Finland

ENMG

4.8

85.8

199

429

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

3.5

85.4

306

907

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.7

85.2

2538

17878

R4110, ,

SPAT

2.4

84.7

651

2905

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.8

84.6

1599

9903

M65.4

ICD-10 Finland

Radial styloid tenosynovitis [de Quervain]

4.9

84.5

191

403

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.7

84.2

490

1917

N17

ICPC

Vertigo/dizziness

2.1

84.1

876

4429

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.6

84.1

532

2169

Z50.1

ICD-10 Finland

Other physical therapy

3.0

83.8

396

1386

E66.8

ICD-10 Finland

Other obesity

2.9

83.4

403

1428

TNF11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in hip joint

32.0

83.4

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.8

83.1

1868

12161

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

2.2

83.1

788

3840

NGF25

NOMESCO Finland

Operation for osteochondritis of knee, arthroscopic

2.8

82.8

431

1591

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

2.2

82.7

804

3956

ZXE00

NOMESCO Finland

One hour or less

1.7

82.6

2455

17241

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.5

82.6

563

2377

N05BA04

ATC

oxazepam; oral

1.8

82.3

1770

11374

M02AA15

ATC

diclofenac; topical

2.5

82.0

557

2348

SHA02

NOMESCO Finland

Stomatognathic treatment, basic

2.7

82.0

479

1877

A07EC01

ATC

sulfasalazine; oral, rectal

2.5

81.6

554

2335

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

2.0

81.1

1106

6161

N05AH04

ATC

quetiapine; oral

2.0

80.9

1069

5890

R05FA02

ATC

opium derivatives and expectorants; systemic

1.7

80.6

2655

19117

7265A

ICD-9 Finland

Peripheral enthesopathies and allied syndromes, Enthesopathy of hip region[BURSITIS TROCHANTERICA]

+∞

80.4

Z2221

NOMESCO Finland

Medical doctor

1.7

80.3

1806

11741

A97

ICPC

No disease

1.9

80.2

1179

6732

M19.1

ICD-10 Finland

Post-traumatic arthrosis of other joints

4.4

80.1

203

470

S43.4

ICD-10 Finland

Sprain and strain of shoulder joint

3.8

79.7

249

673

R13

ICD-10 Finland

Dysphagia

2.6

79.4

482

1924

H92.0

ICD-10 Finland

Otalgia

2.7

79.3

437

1661

R09

ICPC

Sinus symptom/complaint

2.4

79.1

581

2538

H02AB07

ATC

prednisone; oral

2.0

78.8

936

4962

N06AB04

ATC

citalopram; systemic

1.8

78.7

1430

8726

R60.9

ICD-10 Finland

Oedema, unspecified

2.8

78.6

411

1520

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

2.9

78.3

391

1410

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

3.4

78.3

285

853

M21.4

ICD-10 Finland

Flat foot [pes planus] (acquired)

3.7

78.3

256

714

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.8

78.2

1324

7903

M67.0

ICD-10 Finland

Short Achilles tendon (acquired)

46.3

78.0

U02

ICPC

Urinary frequency/urgency

1.9

77.9

1078

6026

WX200

NOMESCO Finland

Interscalenous plexus blockade

5.9

77.9

142

247

C07AA05

ATC

propranolol; systemic

1.8

77.7

1377

8334

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.6

77.5

2825

20801

M65.9

ICD-10 Finland

Synovitis and tenosynovitis, unspecified

5.0

77.5

168

342

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.2

77.0

695

3315

R20.2

ICD-10 Finland

Paraesthesia of skin

2.6

76.9

467

1864

G43.9

ICD-10 Finland

Migraine, unspecified

2.8

76.7

402

1488

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

2.1

76.6

873

4556

R05FB02

ATC

cough suppressants and expectorants; systemic

1.6

76.6

2497

17866

J01DA09

ATC

[U] cefadroxil

1.7

76.4

1666

10711

R51

ICD-10 Finland

Headache

2.9

76.3

388

1413

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

2.6

76.1

463

1850

A02BA04

ATC

nizatidine; systemic

2.4

75.9

539

2317

M19.8

ICD-10 Finland

Other specified arthrosis

3.2

75.8

309

992

L05

ICPC

Flank/axilla symptom/complaint

2.7

75.7

428

1648

M65.8

ICD-10 Finland

Other synovitis and tenosynovitis

5.4

75.6

151

286

S93.4

ICD-10 Finland

Sprain and strain of ankle

2.3

75.4

650

3040

T84.0

ICD-10 Finland

Mechanical complication of internal joint prosthesis

3.5

75.3

271

805

C10AX09

ATC

ezetimibe; oral

2.0

75.2

969

5281

N03AX09

ATC

lamotrigine; oral

3.2

74.9

314

1025

9242

FHL

Other reconstruction or plastic surgery of shoulder joint (including ac joint)

10.9

74.7

M51.9

ICD-10 Finland

Intervertebral disc disorder, unspecified

6.0

74.4

133

227

M79.9

ICD-10 Finland

Soft tissue disorder, unspecified

10.6

74.3

TPH04

NOMESCO Finland

Cathetrisation of vein

1.8

73.8

1333

8098

S21

ICPC

Skin texture symptom/complaint

2.0

73.7

946

5146

R12

ICD-10 Finland

Heartburn

2.3

73.2

581

2623

NDG60

NOMESCO Finland

Arthroplasty of first CMC joint

5.6

73.1

140

255

M18.1

ICD-10 Finland

Other primary arthrosis of first carpometacarpal joint

4.9

72.8

163

341

NHL16

NOMESCO Finland

Tenolysis or tenosynovectomy of achilles tendon

37.8

72.7

F51.0

ICD-10 Finland

Nonorganic insomnia

1.9

72.2

1004

5611

WZC00

NOMESCO Finland

Treatment plan or consultation

1.6

72.1

2287

16185

D19

ICPC

Teeth/gum symptom/complaint

1.7

71.6

1771

11752

A06AD11

ATC

lactulose; oral

2.0

71.5

914

4962

WX290

NOMESCO Finland

Other blockage of nerve

1.6

70.9

2673

19712

R03AK06

ATC

salmeterol and fluticasone; inhalant

2.0

70.6

893

4827

M67.8

ICD-10 Finland

Other specified disorders of synovium and tendon

11.5

70.6

N02AC04

ATC

dextropropoxyphene; oral

3.5

70.6

249

730

L11

ICPC

Wrist symptom/complaint

2.3

70.3

598

2778

H53.1

ICD-10 Finland

Subjective visual disturbances

2.4

70.3

506

2187

SHA03

NOMESCO Finland

Stomatognathic treatment, demanding

3.7

70.2

229

637

M66.0

ICD-10 Finland

Rupture of popliteal cyst

11.2

70.1

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

2.0

69.9

859

4597

NF2AT

NOMESCO Finland

Injection to hip joint with ultrasound guidance

11.5

69.8

SHA01

NOMESCO Finland

Stomatognathic treatment, simple

2.1

69.6

717

3596

M46.9

ICD-10 Finland

Inflammatory spondylopathy, unspecified

7.6

69.5

130

C10AA07

ATC

rosuvastatin; oral

1.6

69.3

2075

14443

E0000UV, ,

ATC

1.6

69.2

2655

19626

ZXA10

NOMESCO Finland

Bilateral

1.8

69.2

1262

7674

M01AE52

ATC

naproxen and esomeprazole; oral

3.3

69.1

263

809

N05CD07

ATC

temazepam; oral

2.1

69.0

783

4070

M71.2

ICD-10 Finland

Synovial cyst of popliteal space [Baker]

3.8

69.0

219

598

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

2.0

68.9

844

4510

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

2.3

68.8

538

2411

R35

ICD-10 Finland

Polyuria

2.7

68.5

393

1523

TQW40, ,

SPAT

2.4

68.5

511

2243

A04

ICPC

Weakness/tiredness general

1.9

68.3

939

5220

L60.0

ICD-10 Finland

Ingrowing nail

2.9

68.2

324

1136

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

2.3

67.8

567

2614

J05AB01

ATC

aciclovir; systemic

1.7

67.8

1483

9493

NE1BG, ,

SPAT

4.6

67.8

164

366

SFA30

NOMESCO Finland

Three-surface restoration

1.6

67.5

2663

19782

A28

ICPC

Limited function/disability NOS

1.8

67.4

1094

6414

J31.0

ICD-10 Finland

Chronic rhinitis

2.3

67.4

560

2575

NA1AD

NOMESCO Finland

Cervical spine CT examination

3.1

67.4

290

961

D07AC01

ATC

betamethasone; topical

1.6

67.3

2260

16155

N06AB10

ATC

escitalopram; oral

1.8

67.2

1265

7756

P06

ICPC

Sleep disturbance

2.1

67.0

737

3785

D07AB02

ATC

hydrocortisone butyrate; topical

1.7

67.0

1886

12902

J20

ICD-10 Finland

Acute bronchitis

2.1

66.9

700

3528

N05CF02

ATC

zolpidem; oral

1.8

66.7

1188

7163

AB5BT

NOMESCO Finland

Blockage of nerv root with X-ray guidance

8.6

66.6

100

M20.4

ICD-10 Finland

Other hammer toe(s) (acquired)

2.8

66.5

351

1303

NH1BG

NOMESCO Finland

Ankle and foot MRI examination with high intensity magnet

5.7

66.5

125

224

NF1AA, ,

SPAT

3.0

66.0

305

1053

M72.0

ICD-10 Finland

Palmar fascial fibromatosis [Dupuytren]

7.0

65.9

101

147

S06.0

ICD-10 Finland

Concussion

2.2

65.7

643

3158

M45

ICD-10 Finland

Ankylosing spondylitis

4.7

65.7

154

335

R5110, ,

SPAT

2.4

65.6

491

2157

R03BA08

ATC

ciclesonide; inhalant

2.2

65.2

608

2929

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.6

65.2

403

1620

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

1.7

65.2

1582

10401

SAA03

NOMESCO Finland

Extended examination of mouth

1.6

65.1

2309

16689

U01

ICPC

Dysuria/painful urination

2.2

65.0

599

2873

G57.6

ICD-10 Finland

Lesion of plantar nerve

4.1

65.0

180

446

L20

ICPC

Joint symptom/complaint NOS

3.1

64.4

281

939

M46.1

ICD-10 Finland

Sacroiliitis, not elsewhere classified

6.0

63.5

113

192

M09AX01

ATC

hyaluronic acid; parenteral

2.7

63.5

348

1317

M22.4

ICD-10 Finland

Chondromalacia patellae

3.8

63.1

197

532

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

1.6

62.3

3940

32321

M25.2

ICD-10 Finland

Flail joint

7.4

62.2

123

SPAT1260

SPAT

Consultation of another employee

1.8

62.2

1114

6715

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

2.0

62.1

790

4267

N06AB03

ATC

fluoxetine; oral

1.9

62.0

838

4622

J01

ICD-10 Finland

Acute sinusitis

2.6

62.0

387

1563

M71.9

ICD-10 Finland

Bursopathy, unspecified

7.4

61.8

121

SPAT1263

SPAT

Sampling

1.6

61.8

2523

18777

A03

ICPC

Fever

1.9

61.7

953

5487

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

2.1

61.7

608

2992

R06AX22

ATC

ebastine; oral

1.8

61.5

1146

6986

K07.63

ICD-10 Finland

Pain in the jaw joint UNS

4.6

61.2

148

330

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

2.7

61.2

347

1336

M18.0

ICD-10 Finland

Primary arthrosis of first carpometacarpal joints, bilateral

4.7

61.0

144

315

SPAT1336

SPAT

Request for examination

3.0

61.0

283

979

R07.0

ICD-10 Finland

Pain in throat

2.4

60.9

434

1864

M94.0

ICD-10 Finland

Chondrocostal junction syndrome [Tietze]

3.7

60.8

193

527

C10AA05

ATC

atorvastatin; oral

1.6

60.6

2528

18878

9473

FHL

Local soft tissue removal or exploration (eg Bursa)

13.0

60.5

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

2.0

60.2

744

3976

S40.0

ICD-10 Finland

Contusion of shoulder and upper arm

3.0

60.2

281

975

I10

ICD-10 Finland

Essential (primary) hypertension

1.5

60.1

3806

31112

SPAT1283

SPAT

Restricted health certificate

1.9

60.0

893

5078

K10.3

ICD-10 Finland

Alveolitis of jaws

2.9

60.0

300

1081

NFB30

NOMESCO Finland

Primary total prosthetic replacement of hip joint not using cement

2.3

59.9

471

2113

M20.1

ICD-10 Finland

Hallux valgus (acquired)

2.1

59.7

657

3368

J46

ICD-10 Finland

Status asthmaticus

3.4

59.7

219

658

K08.80

ICD-10 Finland

Toothache NOS

2.2

59.3

565

2742

F45.8

ICD-10 Finland

Other somatoform disorders

2.4

59.2

426

1837

SPAT1249

SPAT

Treatment-related counselling outside office

1.6

58.7

2368

17518

ZZH21

NOMESCO Finland

Graft of patients own bone, small pieces

3.9

58.6

173

449

A08

ICPC

Swelling

2.5

58.6

373

1520

NF1BA

NOMESCO Finland

Hip extensive X-ray examination

2.9

58.4

276

964

ABC16

NOMESCO Finland

Microsurgical excision of lumbar intervertebral disc displacement

3.3

58.3

229

718

M24.8

ICD-10 Finland

Other specific joint derangements, not elsewhere classified

9.3

58.3

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.6

58.3

1627

11037

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.6

58.1

1774

12298

J45.1

ICD-10 Finland

Nonallergic asthma

2.3

57.9

478

2188

M15.8

ICD-10 Finland

Other polyarthrosis

3.8

57.9

179

480

XF400

NOMESCO Finland

ECG with 12 standard connections

1.9

57.8

896

5158

R11

ICD-10 Finland

Nausea and vomiting

2.1

57.8

558

2722

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.6

57.6

1595

10794

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.8

57.5

1106

6793

SPAT1301

SPAT

No procedures

1.6

57.4

1891

13342

R51.81

ICD-10 Finland

Facial pain NOS

3.6

57.3

191

539

Z01.7

ICD-10 Finland

Laboratory examination

1.8

57.3

945

5544

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.7

57.3

1259

8022

L09

ICPC

Arm symptom/complaint

2.7

57.0

322

1237

SPAT1229

SPAT

Assessment of need for aid

2.2

57.0

514

2440

M01AG02

ATC

tolfenamic acid; oral, rectal

1.8

56.9

1059

6440

N39.3

ICD-10 Finland

Stress incontinence

2.1

56.9

621

3173

Z00.0

ICD-10 Finland

General medical examination

1.7

56.6

1138

7073

NH3FA

NOMESCO Finland

Weight-bearing X-ray of foot

4.3

56.5

149

356

7261X

ICD-9 Finland

Peripheral enthesopathies and allied syndromes, Rotator cuff syndrome of shoulder and allied disorders[MUU TAI TARKEMMIN MÄÄRITTELEM KIERTÄJÄKALVOSINSDR]

+∞

56.3

U07

ICPC

Urine symptom/complaint other

2.2

56.3

515

2458

M35.3

ICD-10 Finland

Polymyalgia rheumatica

2.8

56.3

295

1090

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

2.4

56.2

428

1892

P03

ICPC

Feeling depressed

2.1

56.1

543

2651

NHG77

NOMESCO Finland

Arthroplasty of interphalangeal tarsal joint(s)

3.5

55.9

198

582

NF1DA

NOMESCO Finland

X-ray of hips

3.8

55.9

172

460

EB1AA, ,

SPAT

2.2

55.8

475

2202

J01FA15

ATC

telithromycin; oral

2.0

55.7

652

3414

G55.2*M47.9

ICD-10 Finland

Nerve root and plexus compressions in spondylosis

4.7

55.6

130

282

L04

ICPC

Chest symptom/complaint

2.4

55.4

421

1859

NB1AT

NOMESCO Finland

Puncture of shoulder with ultrasound guidance

15.0

55.3

S22.3

ICD-10 Finland

Fracture of rib

2.4

55.3

396

1703

NGF35

NOMESCO Finland

Plastic operation of joint cartilage of knee

3.3

55.3

214

665

A03CA02

ATC

clidinium and psycholeptics; oral

2.4

55.1

405

1762

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.3

55.1

445

2017

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

3.5

55.1

194

568

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

2.4

55.0

397

1714

M75

ICD-10 Finland

Shoulder lesions

2.8

54.9

293

1093

S01GX01

ATC

cromoglicic acid; ophthalmic

1.7

54.5

1309

8525

NHG80

NOMESCO Finland

Fusion of first tarsometatarsal joint

2.8

54.3

287

1065

A01AB09

ATC

miconazole; local oral

2.1

54.2

594

3037

G50.1

ICD-10 Finland

Atypical facial pain

4.3

54.1

143

342

NB1BA

NOMESCO Finland

Shoulder extensive X-ray examination without contrast

3.3

53.8

212

666

XKD00

NOMESCO Finland

Uroflowmetry

2.1

53.8

584

2975

S70.0

ICD-10 Finland

Contusion of hip

2.9

53.8

254

887

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.7

53.5

1267

8217

S01

ICPC

Pain/tenderness of skin

2.7

53.5

303

1165

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.7

53.5

1166

7399

281

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab

3.4

53.4

197

594

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

2.5

53.4

350

1445

L18

ICPC

Muscle pain

2.8

53.4

277

1018

C08CA01

ATC

amlodipine; oral

1.5

53.1

2322

17384

XX9AW

NOMESCO Finland

Production of copy from X-ray picture

3.0

53.0

241

824

M53.3

ICD-10 Finland

Sacrococcygeal disorders, not elsewhere classified

5.2

52.9

110

216

L03.0

ICD-10 Finland

Cellulitis of finger and toe

2.2

52.9

480

2283

D02

ICPC

Abdominal pain epigastric

2.3

52.7

418

1880

L10

ICPC

Elbow symptom/complaint

2.7

52.7

304

1180

J01CA08

ATC

pivmecillinam; oral

1.5

52.6

3097

24634

NE1DG

NOMESCO Finland

Pelvic, hip and femur very extensive MRI examination with high intensity magnet

8.8

52.6

S83.6

ICD-10 Finland

Sprain and strain of other and unspecified parts of knee

2.6

52.4

317

1259

R25.2

ICD-10 Finland

Cramp and spasm

3.7

52.4

168

462

TNB11, ,

SPAT

9.6

52.1

K59.0

ICD-10 Finland

Constipation

2.4

51.9

359

1519

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

2.6

51.9

301

1171

J01MA12

ATC

levofloxacin; systemic

1.7

51.8

1054

6559

A01AB04

ATC

amphotericin B; local oral

2.4

51.7

358

1516

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

3.2

51.7

204

642

M19

ICD-10 Finland

Other arthrosis

3.4

51.4

185

549

M23.8

ICD-10 Finland

Other internal derangements of knee

3.0

51.3

233

796

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.5

51.2

1913

13815

S22

ICPC

Nail symptom/complaint

2.3

51.2

411

1858

F29

ICPC

Eye symptom/complaint other

2.0

50.9

617

3268

G04BD08

ATC

solifenacin; oral

2.2

50.8

453

2138

NA3BG, ,

SPAT

2.8

50.8

257

932

Z02.7

ICD-10 Finland

Issue of medical certificate

2.2

50.5

433

2011

TAB20

NOMESCO Finland

Epidural puncture

6.2

50.5

140

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.7

50.5

1073

6752

SPAT1202

SPAT

Intra-articular injection

3.0

50.5

229

782

R83

ICPC

Respiratory infection other

1.6

50.4

1413

9544

M70.9

ICD-10 Finland

Unspecified soft tissue disorder related to use, overuse and pressure

8.1

50.3

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

3.4

50.3

183

547

73109

ICD-8 Finland

Synovitis, bursitis and tenosynovitis, Unspecified

+∞

50.1

XF402

NOMESCO Finland

ECG with work load test

2.0

50.0

622

3322

NA7EA

NOMESCO Finland

Scoliosis X-ray examination

5.0

49.9

107

216

L89

ICPC

Osteoarthrosis of hip

2.7

49.9

284

1095

NHU20

NOMESCO Finland

Removal of internal fixation device from ankle or foot

2.6

49.5

291

1140

M43.0

ICD-10 Finland

Spondylolysis

4.4

49.5

126

293

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.7

49.4

938

5716

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.8

49.4

773

4449

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.6

49.4

1300

8640

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.8

49.2

759

4348

A99

ICPC

Disease/condition unspecnature/site

2.0

49.1

583

3063

TQW40

NOMESCO Finland

Remowal of suture of skin

2.2

48.8

448

2139

L99

ICPC

Musculoskeletal disease other

3.6

48.7

165

471

NDM10

NOMESCO Finland

Palmar fasciotomy of hand

16.5

48.7

NH1CG

NOMESCO Finland

Ankle and foot extensive MRI examination with high intensity magnet

5.9

48.7

152

ABD32

NOMESCO Finland

Implantation of temporary spinal stimulation device

10.1

48.6

C05AA08

ATC

fluocortolone; rectal, topical

1.8

48.6

856

5105

M01AB01

ATC

indometacin; systemic, rectal

2.3

48.5

390

1763

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.6

48.5

1399

9503

N03AF01

ATC

carbamazepine; oral, rectal

2.5

48.5

315

1295

XQ800

NOMESCO Finland

Prick test

2.2

48.5

456

2198

D07AC13

ATC

mometasone; topical

1.5

48.4

1747

12490

M77.8

ICD-10 Finland

Other enthesopathies, not elsewhere classified

8.9

48.4

L84

ICPC

Back syndrome without radiat pain

2.5

48.2

318

1316

R03AC13

ATC

formoterol; inhalant

2.4

48.2

336

1427

M79.8

ICD-10 Finland

Other specified soft tissue disorders

12.1

47.9

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

2.2

47.7

409

1899

A46

ICD-10 Finland

Erysipelas

1.8

47.6

789

4618

T78.4

ICD-10 Finland

Allergy, unspecified

2.6

47.6

296

1192

JBC01

NOMESCO Finland

Laparoscopic gastro-oesophageal antireflux operation

4.0

47.5

135

341

AB5CT

NOMESCO Finland

Blockage of nerv root with CT guidance

9.3

47.4

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

3.1

47.2

199

651

A07AA02

ATC

nystatin; oral

2.2

47.2

407

1894

L01BA01

ATC

methotrexate; systemic

2.7

47.2

266

1020

SPAT1312

SPAT

General health counselling

1.5

47.2

1842

13384

JHB30

NOMESCO Finland

Rubber band ligature of haemorrhoids or prolapse of mucosa

2.3

47.1

388

1772

AEA00

NOMESCO Finland

Replacement of impulse generator of stimulation device in the nervous system

10.7

47.0

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

3.4

47.0

173

521

WZA00

NOMESCO Finland

Concise certificate

2.3

47.0

388

1773

N06AX26

ATC

vortioxetine; oral

2.2

47.0

417

1963

N06AB06

ATC

sertraline; oral

1.9

47.0

666

3713

H60.9

ICD-10 Finland

Otitis externa, unspecified

2.2

47.0

442

2130

W19

ICD-10 Finland

Unspecified fall

2.0

47.0

571

3024

SDA01

NOMESCO Finland

Periodontal treatment, very brief

1.6

46.8

1605

11332

J01DA06

ATC

[U] cefuroxime

1.7

46.7

883

5370

H02.3

ICD-10 Finland

Blepharochalasis

2.1

46.6

471

2333

KMAK, ,

NOMESCO Finland

1.5

46.6

2994

24019

XKC03

NOMESCO Finland

Water cystometry

2.9

46.4

227

808

9476

FHL

Splitting of fascia or aponeurosis

10.5

46.4

NBE35

NOMESCO Finland

Transposition of ligament of shoulder, arthroscopic

9.0

46.3

ACC53

NOMESCO Finland

Release of ulnar nerve

5.5

46.3

163

R00.2

ICD-10 Finland

Palpitations

2.0

46.2

510

2609

WZC00, ,

SPAT

1.9

46.2

602

3263

M89.0

ICD-10 Finland

Algoneurodystrophy

7.6

46.2

Z71.9

ICD-10 Finland

Counselling, unspecified

2.1

46.2

458

2252

SGA01

NOMESCO Finland

Emergency treatment

1.7

46.2

883

5386

SPAT1310

SPAT

Counselling related to known health issue

1.5

46.1

1864

13628

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.4

46.1

339

1474

SPAT1216

SPAT

Assessment of functional ability

1.7

46.0

950

5919

JN3AD

NOMESCO Finland

Abdominal CT examination

1.9

45.9

672

3783

7290A

ICD-9 Finland

Other disorders of soft tissues, Rheumatism, unspecified and fibrositis

+∞

45.9

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

2.0

45.7

519

2683

K59.1

ICD-10 Finland

Functional diarrhoea

2.3

45.5

373

1699

N62

ICD-10 Finland

Hypertrophy of breast

2.5

45.4

300

1243

M24.2

ICD-10 Finland

Disorder of ligament

5.7

45.3

152

C01CA24

ATC

epinephrine; parenteral

2.2

45.3

388

1800

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

2.0

45.2

523

2722

R10.0

ICD-10 Finland

Acute abdomen

2.9

45.1

211

733

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

2.8

45.1

231

843

C09CA06

ATC

candesartan; oral

1.6

45.1

1490

10421

NCL22

NOMESCO Finland

Myotomy or tenotomy of elbow or forearm

231.6

45.0

R55

ICD-10 Finland

Syncope and collapse

1.9

44.9

627

3477

R10.2

ICD-10 Finland

Pelvic and perineal pain

3.4

44.5

160

475

G25.8

ICD-10 Finland

Other specified extrapyramidal and movement disorders

3.0

44.5

201

685

R75

ICPC

Sinusitis acute/chronic

2.4

44.3

309

1312

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.7

44.2

955

6016

R03BB04

ATC

tiotropium bromide; inhalant

2.0

44.1

547

2914

SPAT1058

SPAT

PEF monitoring instruction

2.0

44.1

522

2737

R01AD01

ATC

beclometasone; nasal

1.7

44.1

950

5981

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.5

44.0

293

1218

SCA01

NOMESCO Finland

Preventive oral health care, short

1.5

43.8

1601

11435

NFF25

NOMESCO Finland

Cleaning of hip joint, arthroscopic

11.6

43.8

UJF30

NOMESCO Finland

Ileoscopy through colon

1.9

43.8

616

3423

SFA00

NOMESCO Finland

Small restoration

1.7

43.7

828

5032

R07

ICPC

Sneezing/nasal congestion

2.2

43.7

374

1735

M71.3

ICD-10 Finland

Other bursal cyst

17.2

43.7

NFL30

NOMESCO Finland

Transposition of muscle of hip or thigh

5.5

43.6

154

N06AX12

ATC

bupropion; oral

2.2

43.6

366

1684

R03AK08

ATC

formoterol and beclometasone; inhalant

2.4

43.6

296

1242

D07AD01

ATC

clobetasol; topical

1.6

43.5

1084

7084

M47.1

ICD-10 Finland

Other spondylosis with myelopathy

5.1

43.4

184

NG1CG

NOMESCO Finland

Knee and lower leg extensive MRI examination with high intensity magnet

3.9

43.3

130

342

R06.5

ICD-10 Finland

Mouth breathing

2.1

43.2

464

2349

SPAT1325

SPAT

Vaccination

1.5

43.1

2009

15079

M54.0

ICD-10 Finland

Panniculitis affecting regions of neck and back

4.4

43.1

107

244

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

2.0

43.1

498

2589

NAG63

NOMESCO Finland

Posterior fusion of lumbar spine with fixation, more than 3 vertebraea

6.6

42.9

106

S13.4

ICD-10 Finland

Sprain and strain of cervical spine

2.8

42.8

219

799

J01MA06

ATC

norfloxacin; oral

1.7

42.7

898

5612

P01

ICPC

Feeling anxious/nervous/tense

1.9

42.7

572

3126

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.8

42.7

773

4635

D82

ICPC

Teeth/gum disease

1.5

42.7

2111

16025

NFL20

NOMESCO Finland

Freeing of muscle of hip or thigh

14.7

42.5

R5140

NOMESCO Finland

Monitoring the use of the aid

1.9

42.4

579

3184

D09

ICPC

Nausea

2.5

42.4

271

1105

R49.01

ICD-10 Finland

Functional dysphonia

2.8

42.4

216

786

G04CA02

ATC

tamsulosin; oral

1.8

42.4

660

3785

SPAT1210

SPAT

Application of cast or individual aid

2.5

42.3

282

1173

UDH02

NOMESCO Finland

Rhinopharyngoscopy

2.2

42.0

383

1822

L84

ICD-10 Finland

Corns and callosities

2.7

41.9

223

830

K04.0

ICD-10 Finland

Pulpitis

2.0

41.9

498

2613

L04AA13

ATC

[U] leflunomide

3.0

41.9

188

638

K03.80

ICD-10 Finland

Irradiated enamel

2.3

41.6

344

1572

M03BX01

ATC

baclofen; systemic

3.9

41.6

125

329

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.8

41.6

627

3559

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

2.3

41.5

318

1407

ZXE20

NOMESCO Finland

More than three and less than five hours

1.7

41.5

775

4686

NA1CG

NOMESCO Finland

Cervical spine extensive MRI examination with high intensity magnet

4.0

41.5

117

294

SDA02

NOMESCO Finland

Periodontal treatment, brief

1.5

41.4

2100

15997

L88

ICPC

Rheumatoid/seropositive arthritis

2.4

41.1

282

1188

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.5

41.1

1410

9912

M62.6

ICD-10 Finland

Muscle strain

3.2

41.1

168

540

SDA03

NOMESCO Finland

Periodontal treatment

1.4

41.0

2371

18503

B01AC04

ATC

clopidogrel; oral

1.7

41.0

808

4959

D12

ICPC

Constipation

2.7

40.8

233

899

WX402

NOMESCO Finland

General anaesthesia

1.6

40.8

1241

8490

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.7

40.8

770

4669

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.9

40.8

555

3048

ZYC01

NOMESCO Finland

Remote contact by phone

2.2

40.5

349

1622

M70.2

ICD-10 Finland

Olecranon bursitis

3.7

40.3

131

364

D20

ICPC

Mouth/tongue/lip symptom/complaint

2.4

40.2

299

1306

R50.9

ICD-10 Finland

Fever, unspecified

1.7

40.2

792

4860

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.8

40.0

672

3939

J01MA14

ATC

moxifloxacin; systemic

1.9

40.0

522

2827

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

2.4

40.0

297

1297

TNF10

NOMESCO Finland

Puncture of hip joint

15.3

40.0

Z2446

NOMESCO Finland

Social worker

2.2

39.9

363

1724

H29

ICPC

Ear symptom/complaint other

1.8

39.9

698

4140

Z96.6

ICD-10 Finland

Presence of orthopaedic joint implants

2.3

39.9

307

1361

C10AA03

ATC

pravastatin; oral

2.0

39.9

426

2151

N30.9

ICD-10 Finland

Cystitis, unspecified

2.1

39.9

418

2096

NCL99

NOMESCO Finland

Other operation on muscle or tendon of elbow or forearm

88.7

39.8

WX110, ,

SPAT

2.1

39.8

386

1881

ND1BG

NOMESCO Finland

Wrist and hand MRI examination with high intensity magnet

6.3

39.7

108

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

2.0

39.7

454

2349

U71

ICPC

Cystitis/urinary infection other

2.0

39.7

487

2584

H03AA01

ATC

levothyroxine sodium; systemic

1.5

39.6

1641

11988

NG1EA

NOMESCO Finland

Knee X-ray examination with wrench

4.2

39.5

106

257

P76

ICPC

Depressive disorder

2.2

39.4

364

1740

L04AB04

ATC

adalimumab; parenteral

3.3

39.4

147

447

2402

FHL

External neurolysis of the nerve and possible alteration of the pathway (nerve pressure)

4.1

39.3

110

275

S60.2

ICD-10 Finland

Contusion of other parts of wrist and hand

2.4

39.1

291

1271

M19.2

ICD-10 Finland

Other secondary arthrosis

4.8

39.0

182

N81.6

ICD-10 Finland

Rectocele

1.9

38.7

541

2995

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

1.7

38.7

739

4492

7263A

ICD-9 Finland

Peripheral enthesopathies and allied syndromes, Enthesopathy of elbow region[EPICONDYLITIS LATERALIS HUMERI]

+∞

38.6

N07BA03

ATC

varenicline; oral

2.4

38.5

271

1155

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.7

38.5

827

5190

WYA10

NOMESCO Finland

Emergency care or similar visit

2.0

38.2

430

2212

NHK40

NOMESCO Finland

Osteotomy or rotation osteotomy of II-V metatarsal or tarsal bone

3.6

38.2

128

363

U05

ICPC

Urination problems other

2.3

38.2

301

1348

A29

ICPC

General symptom/complaint other

1.7

38.2

737

4492

I80.29

ICD-10 Finland

Phlebitis and thrombophlebitis of other deep vessels of lower extremities

2.9

38.1

185

656

WX120

NOMESCO Finland

Intravenous local anesthesy of arm

4.5

38.0

210

UJD02

NOMESCO Finland

Gastroscopy

2.3

37.8

290

1284

C01DA14

ATC

isosorbide mononitrate; oral

1.7

37.7

723

4397

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

2.3

37.7

288

1273

WX203

NOMESCO Finland

Infraclavicular plexus blockade

3.2

37.6

153

491

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.4

37.6

274

1187

S15

ICPC

Foreign body in skin

2.1

37.5

384

1908

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.5

37.5

1523

11061

R29

ICPC

Respiratory symptom/complaint other

2.1

37.5

392

1963

M41.9

ICD-10 Finland

Scoliosis, unspecified

3.9

37.5

111

289

UJH02

NOMESCO Finland

Anoscopy

2.4

37.5

272

1175

SPAT1028

SPAT

Ultrasound examination of paranasal sinuses

2.1

37.5

352

1693

S83.2

ICD-10 Finland

Tear of meniscus, current

2.1

37.5

356

1720

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

2.5

37.5

233

938

XF404

NOMESCO Finland

Ambulatory ECG

1.9

37.4

504

2756

S20.2

ICD-10 Finland

Contusion of thorax

2.3

37.3

284

1253

LEF03

NOMESCO Finland

Posterior colporrpahy with sutures for primary rectocele

2.2

37.3

335

1583

F34.1

ICD-10 Finland

Dysthymia

2.6

37.2

218

852

NG1AE

NOMESCO Finland

Knee joint ultrasound exmination

4.6

37.2

197

Y88.3

ICD-10 Finland

Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.9

37.2

180

637

K07.65

ICD-10 Finland

Temporomandibular joint-pain-dysfunction syndrome

5.0

37.2

162

C10AA01

ATC

simvastatin; oral

1.4

37.1

2404

19058

N06AB05

ATC

paroxetine; oral

2.1

37.1

374

1849

F01

ICPC

Eye pain

2.8

37.0

188

683

S04

ICPC

Lump/swelling localized

1.8

37.0

594

3433

S30.0

ICD-10 Finland

Contusion of lower back and pelvis

2.5

37.0

234

950

M01AE51

ATC

ibuprofen, combinations; systemic

3.9

36.9

110

288

S89.9

ICD-10 Finland

Unspecified injury of lower leg

2.7

36.9

208

798

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

2.6

36.8

217

851

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.9

36.7

471

2535

G04BD11

ATC

fesoterodine; oral

2.7

36.7

204

777

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.9

36.7

477

2579

A98

ICPC

Health maint/preventive medicine

2.4

36.6

6265

59845

G57.0

ICD-10 Finland

Lesion of sciatic nerve

10.6

36.6

WZB00, ,

SPAT

2.0

36.6

421

2182

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.7

36.6

704

4286

7227C

ICD-9 Finland

Intervertebral disk disorders, Intervertebral disk disorder with myelopathy[SYNDROMA ISCHIADICUM]

2.9

36.5

179

638

78559

ICD-8 Finland

Symptoms referable to abdomen and lower gastro-intestinal tract, Colica abdominalis NUD

2.5

36.5

232

944

LC2AE

NOMESCO Finland

Ultrasound examination of uterus and parametria

1.7

36.5

703

4281

EB1VA, ,

NOMESCO Finland

1.7

36.4

717

4391

J01FA01

ATC

erythromycin; systemic

1.7

36.3

766

4781

J02AC02

ATC

itraconazole; systemic

1.6

36.3

1117

7643

Z01.4

ICD-10 Finland

Gynaecological examination (general)(routine)

1.5

36.2

1177

8149

SFA40

NOMESCO Finland

Restoration involving the entire crown of the tooth

1.5

36.2

1324

9402

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.8

36.2

568

3259

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.2

36.1

306

1412

K80

ICPC

Cardiac arrhythmia NOS

1.9

36.1

512

2846

J01CE02

ATC

phenoxymethylpenicillin; oral

1.4

36.1

3944

34097

M53.2

ICD-10 Finland

Spinal instabilities

5.7

36.0

119

C09CA01

ATC

losartan; oral

1.5

36.0

1557

11439

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.8

35.9

543

3080

Z09.0

ICD-10 Finland

Follow-up examination after surgery for other conditions

1.8

35.9

547

3111

S76.3

ICD-10 Finland

Injury of muscle and tendon of the posterior muscle group at thigh level

4.0

35.8

103

263

E66

ICD-10 Finland

Obesity

2.2

35.8

310

1444

K03.64

ICD-10 Finland

Dental calculus supragingival

1.4

35.8

1785

13476

WX308

NOMESCO Finland

Sacral anesthesy

10.6

35.7

M96.1

ICD-10 Finland

Postlaminectomy syndrome, not elsewhere classified

6.5

35.7

G55.1

ICD-10 Finland

Nerve root and plexus compressions in intervertebral disc disorders

5.5

35.6

124

R01AD05

ATC

budesonide; nasal

1.9

35.5

478

2614

N30

ICD-10 Finland

Cystitis

1.8

35.4

564

3249

R06AE09

ATC

levocetirizine; oral

1.6

35.4

840

5401

N06AX03

ATC

mianserin; oral

2.2

35.2

303

1407

B01AF01

ATC

rivaroxaban; oral

1.7

35.1

715

4418

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

2.4

35.1

236

986

M17.3

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

1980

8273

3.01

307.65

1.4

1.2

31.06

36.65

iu/ml

0.78

622

2759

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

1944

7766

3.15

307.65

1.4

1.2

10.06

15.00

u/ml

2.16

726

3039

(3013707) Erythrocyte sedimentation rate by Westergren method

5394

39145

3.25

285.84

5.6

3.7

12.68

13.02

mm/h

1.03

5107

35885

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

2005

10052

2.44

218.03

1.9

1.6

0.94

1.24

mg/l

6.97

1557

7660

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

5374

41303

2.76

209.82

8.0

7.2

75.00

79.16

u/l

13.61

5141

38682

(3013115) Eosinophils [#/volume] in Blood

3917

26276

2.24

208.83

6.6

5.7

0.19

e9/l

0.38

3387

22689

(3006315) Basophils [#/volume] in Blood

3820

25419

2.22

207.08

6.4

5.5

0.04

e9/l

1.97

3255

21620

(3001604) Monocytes [#/volume] in Blood

3803

25359

2.21

203.72

6.4

5.5

0.57

e9/l

0.35

3259

21601

(3031040) Bacteria [#/volume] in Urine by Automated count

4768

34939

2.38

201.79

6.3

4.2

694.56

2646.59

e6/l

3.83

495

(3019198) Lymphocytes [#/volume] in Blood

3871

26090

2.20

200.51

6.4

5.5

1.96

1.91

e9/l

1.14

3371

22750

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

2553

14602

2.23

200.44

2.3

1.9

165.51

203.77

u/l

1.78

2444

13567

(40760892) CBC W Ordered Manual Differential panel - Blood

3591

23741

2.15

192.20

6.8

6.0

—

(3037467) Urinalysis macro (dipstick) panel - Urine

4834

36055

2.34

189.34

5.8

4.1

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

4254

30258

2.18

185.37

8.4

9.2

4.11

4.00

e9/l

2.45

3677

26161

(3037522) Nuclear Ab [Titer] in Serum

1400

6406

2.51

181.45

1.4

1.3

501.14

576.81

titre

0.72

280

1475

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

3882

26791

2.12

181.19

6.5

6.1

1.22

mmol/l

1.17

3397

22456

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

3572

24062

2.08

175.78

5.7

5.4

1.22

mmol/l

0.41

3281

21701

(3011397) Hemoglobin [Presence] in Urine by Test strip

2157

12129

2.17

170.78

4.5

3.6

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

3260

21513

2.04

166.50

2.2

1.9

97.98

97.37

pmol/l

0.28

1628

10445

(3021601) Nitrite [Presence] in Urine by Test strip

3718

25742

2.04

165.73

6.3

4.8

0.00

estimate

1.34

606

4579

(3009261) Glucose [Presence] in Urine by Test strip

3746

26007

2.04

165.69

4.8

3.6

0.00

estimate

0.02

599

4556

(3026493) Urate [Moles/volume] in Serum or Plasma

2149

12212

2.14

164.34

2.4

1948.04

5627.01

umol/l

6.36

1843

10654

(3035350) Ketones [Presence] in Urine by Test strip

3697

25599

2.03

164.08

4.8

3.6

0.00

estimate

0.03

639

4923

(3013826) Glucose [Moles/volume] in Serum or Plasma

4114

29724

2.05

160.57

5.0

4.2

6.58

6.67

mmol/l

2.06

3919

27643

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

3866

27418

2.02

157.70

5.2

6.2

9.78

11.08

umol/l

15.47

3681

25934

(3015736) pH of Urine

3112

20536

1.99

155.28

4.4

3.3

5.88

0.03

152

1524

(3018095) Leukocytes [#/volume] in Urine

2799

17805

2.01

155.12

4.6

3.3

76.83

122.05

e6/l

2.65

1966

11978

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

6178

53478

4.32

155.04

19.3

12.5

19.47

23.56

mg/l

22.93

5265

41234

(3030467) Casts [#/volume] in Urine by Automated count

2268

13592

2.03

146.77

3.7

2.9

0.33

0.49

e6/l

2.92

1720

10047

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

2495

15600

1.97

141.94

3.0

2.4

55.14

62.05

u/l

4.30

2322

14255

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

3354

23189

1.93

141.00

2.6

2.2

79.00

79.27

nmol/l

0.22

3031

20673

(36304419) Bacteria [Presence] in Urine

2209

13266

2.01

140.88

3.6

2.8

—

(3006504) Eosinophils/100 leukocytes in Blood

3404

23914

1.89

133.49

6.8

5.6

2.80

2.81

0.13

3199

22202

(3018418) pH of Serum or Plasma

2522

16079

1.93

133.31

3.8

7.40

0.14

352

3042

(3022096) Basophils/100 leukocytes in Blood

3311

23098

1.89

132.27

6.8

5.7

0.71

0.69

0.74

3091

21384

(3019069) Monocytes/100 leukocytes in Blood

3415

24060

1.89

132.26

7.1

5.9

8.38

8.48

1.04

3203

22383

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

5290

43337

2.20

129.80

5.1

4.2

14.80

14.83

pmol/l

0.44

4907

39268

(3002030) Lymphocytes/100 leukocytes in Blood

3471

24697

1.87

129.12

6.9

5.7

28.48

28.03

1.68

3266

23032

(3018010) Neutrophils/100 leukocytes in Blood

3422

24317

1.86

127.01

6.7

5.5

56.90

57.26

1.06

3217

22656

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

5910

51004

2.80

125.31

6.3

4.9

1.80

2.17

mu/l

3.44

5563

46498

(3002582) Erythrocytes [#/volume] in Urine

2338

14796

1.91

124.25

3.8

2.9

30.53

96.03

e6/l

4.21

1783

10992

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1517

8327

2.07

121.12

3.1

2.5

1.55

1.69

e6/l

0.12

837

4568

(3024561) Albumin [Mass/volume] in Serum or Plasma

3249

22987

1.83

119.60

4.4

36.09

35.48

g/l

9.56

3024

21249

(3022217) INR in Platelet poor plasma by Coagulation assay

3258

23127

1.82

118.08

14.2

13.4

1.18

1.25

inr

2.16

858

6575

(3019150) Specific gravity of Urine by Refractometry

1828

10844

1.96

116.53

5.3

4.0

1.02

1.01

kg/l

0.27

254

1648

(3001122) Ferritin [Mass/volume] in Serum or Plasma

3141

22113

1.82

116.41

3.2

2.7

106.66

118.52

ug/l

1.87

2905

20388

(40768797) Stomach Pathology biopsy report

1319

7001

2.11

114.43

1.3

1.2

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

2758

18772

1.82

113.42

4.2

3.2

64.49

64.92

ng/l

0.00

1877

12461

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

3341

24170

1.79

111.06

2.7

2.4

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

6247

56224

4.08

110.87

20.7

14.4

139.69

139.72

mmol/l

0.49

6176

54643

(3023103) Potassium [Moles/volume] in Serum or Plasma

6252

56395

4.07

108.50

20.9

14.6

3.96

3.95

mmol/l

4.05

6174

54689

(3000850) Epithelial cells [#/volume] in Urine

1697

10058

1.93

106.95

2.9

2.4

6.68

6.96

e6/l

0.33

1555

8922

(3026008) Bacteria identified in Urine by Culture

2591

17633

1.78

103.99

3.9

3.0

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1610

9500

1.92

102.12

4.3

3.3

288.15

454.97

ng/l

0.66

1205

7293

(3048689) Calprotectin [Mass/mass] in Stool

1115

5788

2.12

101.36

2.0

2.1

99.66

126.34

ug/g

2.72

861

4494

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1802

11072

1.87

100.64

1.3

1.2

1.39

1.74

u/ml

0.84

505

2923

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1937

12249

1.83

98.18

2.5

2.2

2.83

3.03

mg/l

3.79

1668

10351

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

4054

31629

1.75

98.05

3.2

2.7

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

2164

14191

1.79

96.88

3.0

2.8

1083.81

1370.19

ng/l

2.18

1867

12160

(3044889) 12 lead EKG panel

4665

38096

1.80

94.14

4.3

3.5

—

(3008898) HLA-B27 [Presence]

397

1319

3.14

92.16

1.1

1.0

—

(40758558) Short blood count panel - Blood

2044

13351

1.78

91.67

5.9

7.0

—

(3007853) Bacteria identified in Skin by Aerobe culture

1031

5386

2.09

91.37

1.9

1.7

—

(3042936) Bacteria identified in Isolate by Culture

1153

6293

2.01

90.53

2.1

1.9

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1337

7700

1.93

89.70

3.4

2.6

3.68

3.64

e6/l

0.04

660

3981

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

5698

49948

2.17

89.20

6.5

5.4

39.66

39.46

mmol/mol

0.99

5338

45731

(3015171) Extractable nuclear Ab [Units/volume] in Serum

491

1869

2.76

89.09

1.3

1.2

0.76

1.21

u/ml

0.40

140

(3021960) Folate [Moles/volume] in Serum or Plasma

1853

11867

1.79

88.27

1.6

1.5

21.93

21.27

nmol/l

0.63

1590

9999

(3033658) Prothrombin time (PT) actual/Normal

2005

13144

1.76

88.07

4.0

3.5

95.10

92.59

4.39

1945

12799

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

912

4662

2.11

85.17

2.5

2.2

46.61

38.61

u/l

0.22

758

3948

(3015377) Calcium [Moles/volume] in Serum or Plasma

2664

19032

1.68

84.54

2.9

3.5

2.36

mmol/l

0.40

2335

16633

(3007164) IgA [Mass/volume] in Serum or Plasma

1549

9507

1.83

84.45

1.5

2.27

2.38

g/l

1.31

873

5553

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2369

16488

1.69

82.47

3.1

31.06

35.39

u/l

1.27

2256

15605

(3044640) Blood type and Crossmatch panel - Blood

2374

16575

1.68

81.39

2.5

2.2

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

5928

53232

2.33

80.14

5.3

4.4

5.92

5.87

mmol/l

2.45

5511

48219

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

6276

58080

3.55

77.16

13.2

9.9

24.56

24.61

u/l

0.08

6137

55753

(3029937) Albumin [Presence] in Urine by Test strip

2009

13599

1.69

76.29

5.4

3.9

0.00

estimate

0.07

603

4489

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

5773

51606

2.09

73.96

16.5

12.1

79.84

79.33

ml/min/173m2

1.09

4824

42105

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

2669

19628

1.61

71.92

5.2

3.8

—

(40761511) CBC panel - Blood by Automated count

6128

56286

2.63

70.88

17.0

12.0

—

(40761535) Cells panel - Urine sediment

780

4040

2.06

69.46

4.1

3.4

—

(3026782) Osmolality of Urine

1510

9661

1.73

69.40

3.3

2.7

517.14

519.48

mosm/kgh2o

0.16

1311

8222

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

1312

8097

1.78

68.28

1.6

1.4

—

(3023368) Bacteria identified in Blood by Culture

1884

12835

1.66

68.26

4.4

4.0

—

(3000475) Leukocytes [#/volume] in Synovial fluid

275

879

3.22

67.90

1.5

1.6

11337.54

12222.64

e6/l

0.11

182

631

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

4150

34127

1.60

67.84

3.5

2.9

46.14

45.85

u/l

0.09

3871

31526

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

924

5149

1.93

66.58

1.9

1.7

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1236

7613

1.77

64.32

2.0

1.7

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

823

4464

1.97

64.06

2.2

349.60

389.39

nmol/l

6.99

752

4091

(3021589) Normoblasts [#/volume] in Blood

3034

23407

1.56

63.98

10.0

8.9

0.00

e9/l

0.20

2437

18988

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

915

5160

1.90

63.36

2.0

1.7

—

(3000494) Fungus identified in Specimen by Culture

988

5728

1.86

62.70

1.6

1.4

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1805

12420

1.63

61.65

2.5

2.1

—

(3019309) Folate [Moles/volume] in Red Blood Cells

1453

9518

1.68

59.95

1.8

1.7

1191.18

1178.22

nmol/l

0.21

1119

7048

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

637

3230

2.08

59.65

2.4

2.3

24.69

24.84

au/ml

0.01

273

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

593

2941

2.12

58.86

1.3

1.2

46.75

49.51

au/ml

0.09

187

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1553

10402

1.65

58.57

2.7

3.0

2.45

2.46

mmol/l

1.63

1360

9133

(3022948) Iron [Moles/volume] in Serum or Plasma

1204

7546

1.73

58.30

2.7

2.3

12.87

12.83

umol/l

0.07

1115

6993

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

5993

55145

2.15

58.28

5.8

4.8

2.78

2.84

mmol/l

6.25

5597

50434

(3002385) Erythrocyte distribution width [Ratio]

5272

46718

1.69

56.78

21.7

15.3

14.90

14.98

0.48

5230

45785

(3013139) Helicobacter pylori Ag [Presence] in Stool

680

3592

2.00

56.76

1.3

1.2

—

(3009542) Hematocrit [Volume Fraction] of Blood

6367

60373

4.10

56.52

27.9

18.9

39.79

39.86

0.19

6039

56251

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

350

1409

2.57

56.35

1.7

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

731

3976

1.95

56.02

3.5

3.4

85.79

87.15

ng/l

0.15

643

3375

(3007461) Platelets [#/volume] in Blood

6369

60445

4.11

55.61

28.0

18.8

261.29

257.79

e9/l

4.37

6241

58544

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

965

5757

1.79

55.20

2.5

5.35

8.38

umol/l

9.11

809

4937

(3035941) MCH [Entitic mass]

6369

60470

4.08

55.05

27.8

18.8

30.31

30.23

3.11

6332

59408

(3024731) MCV [Entitic volume]

6369

60476

4.08

54.92

27.9

18.8

91.47

91.11

8.79

6332

59415

(3010813) Leukocytes [#/volume] in Blood

6369

60477

4.07

54.90

28.0

18.8

6.79

6.57

e9/l

11.58

6232

58370

(3026361) Erythrocytes [#/volume] in Blood

6369

60482

4.07

54.79

28.0

18.8

4.40

4.43

e12/l

5.37

6231

58398

(3005322) IgE [Units/volume] in Serum or Plasma

570

2865

2.08

54.47

1.3

158.16

201.24

u/ml

1.03

523

2616

(3000963) Hemoglobin [Mass/volume] in Blood

6369

60497

4.05

54.45

28.1

18.9

132.73

133.23

g/l

2.56

6333

59446

(4200892) Spirometry reversibility

674

3638

1.95

52.68

1.5

1.4

—

(3009508) Creatinine [Moles/volume] in Urine

2110

15536

1.53

51.81

3.0

6.98

6.82

mmol/l

0.94

1802

12985

(3044941) Cell count panel - Synovial fluid

191

576

3.39

51.79

1.4

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

5875

54066

1.93

51.09

5.0

4.3

4.76

4.83

mmol/l

6.37

5491

49668

(3021788) Differential panel - Synovial fluid

209

678

3.15

50.32

1.5

—

(3004588) Protein electrophoresis panel - Serum or Plasma

605

3206

1.98

49.78

2.2

2.5

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1242

8149

1.65

49.73

2.7

3.3

0.82

mmol/l

0.24

1143

7579

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

650

3532

1.93

49.68

1.7

1.6

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1087

6952

1.68

47.87

2.7

2.3

2.38

2.35

g/l

0.73

994

6386

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

5822

53665

1.83

46.89

5.0

4.2

1.53

1.56

mmol/l

8.25

5407

49037

(3027801) Oxygen [Partial pressure] in Arterial blood

880

5345

1.75

46.74

6.1

6.9

12.11

12.64

kpa

2.55

843

5100

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

880

5348

1.75

46.64

6.1

6.9

5.04

5.11

kpa

1.27

839

5100

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

696

3950

1.85

46.39

2.5

2.2

6.01

7.26

ug/l

0.68

595

3382

(3003396) Base excess in Arterial blood by calculation

878

5345

1.74

46.22

6.1

6.9

1.14

1.19

mmol/l

0.16

715

4302

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1120

7295

1.65

45.75

2.3

2.0

29.31

29.66

1.24

1084

7089

(3012516) Albumin [Mass/volume] in Urine

1995

14817

1.50

45.69

3.0

3.1

430.16

337.08

mg/l

0.37

1229

8631

(3020682) Albumin/Creatinine [Ratio] in Urine

2079

15645

1.48

44.32

3.5

3.6

8.11

8.08

mg/mmol

0.01

1258

9180

(36660697) Celiac disease serology panel - Serum

687

3946

1.83

43.94

1.2

1.1

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

699

4044

1.82

43.65

5.8

6.3

1.23

1.32

mmol/l

2.22

680

3948

(3020630) Protein [Mass/volume] in Serum or Plasma

679

3898

1.83

43.49

2.3

2.8

66.42

66.39

g/l

0.04

602

3516

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1014

6519

1.66

43.38

2.7

2.4

21.14

22.07

1.42

864

5568

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

319

1390

2.36

43.16

1.4

1.3

20.13

57.51

u/ml

2.73

(40768804) Tissue Pathology biopsy report

2879

23155

1.44

42.88

2.2

2.1

—

(3003338) MCHC [Mass/volume]

5087

45564

1.54

42.84

24.7

16.6

330.65

331.06

g/l

2.97

5070

45218

(3016502) Oxygen saturation in Arterial blood

773

4648

1.75

42.27

6.4

7.3

95.94

95.82

0.22

744

4468

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1933

14479

1.48

41.59

1.7

1.6

1.45

1.34

mmol/l

4.56

1657

12051

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

208

752

2.82

41.34

1.8

1.6

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

250

1001

2.56

40.64

1.4

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

514

2766

1.93

40.16

1.7

1.6

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

725

4355

1.75

39.65

6.7

7.7

120.73

119.73

g/l

0.69

710

4233

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

289

1265

2.34

38.68

1.4

1.3

3.35

7.73

u/ml

1.92

225

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

368

1789

2.12

38.12

2.2

2.3

7.45

7.48

g/l

0.10

327

1591

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

367

1788

2.12

37.80

2.2

2.3

—

(3003327) Ova and parasites identified in Stool by Light microscopy

332

1558

2.19

37.63

1.7

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

366

1788

2.11

37.43

2.2

2.3

3.55

3.66

g/l

0.74

326

1590

(3022145) Colonoscopy Study observation

891

5741

1.64

37.34

1.3

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

313

1439

2.23

37.31

1.3

1.2

—

(3000991) Gas panel - Venous blood

649

3844

1.76

37.17

7.0

7.6

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

5601

51696

1.61

37.05

4.4

3.8

1.36

1.26

mmol/l

18.10

5152

46777

(3000570) Elastase.pancreatic [Mass/mass] in Stool

304

1386

2.25

36.97

1.4

305.08

272.56

ug/g

2.08

180

820

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

309

1421

2.23

36.81

1.3

1.2

—

(42529406) Shigella sp [Presence] in Stool by Culture

312

1445

2.22

36.52

1.3

1.2

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

247

1042

2.42

35.92

1.3

1.2

40.77

45.29

u/ml

0.14

117

(3000492) Spirometry study

741

4597

1.69

35.86

1.5

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

282

1262

2.29

35.85

1.4

1.3

5.47

4.44

u/ml

0.27

139

(3023520) Reticulocytes [#/volume] in Blood

643

3844

1.75

35.59

2.4

2.5

70.40

69.84

e9/l

0.14

466

2884

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

302

1398

2.22

35.39

1.7

1.6

1.20

1.19

g/l

0.54

284

1320

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

344

1678

2.11

35.30

2.3

2.93

3.00

g/l

0.75

303

1481

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

391

2004

2.01

35.08

1.1

0.85

2.21

u/ml

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

295

1364

2.22

34.67

1.7

1.6

0.24

0.23

g/l

0.44

276

1284

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

341

1680

2.09

34.08

2.1

2.3

9.43

10.41

g/l

3.87

296

1472

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

290

1342

2.22

34.01

1.5

1.6

5.00

0.19

iu/ml

0.49

272

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

194

4.37

33.36

1.3

1.5

4.82

6.34

u/l

1.23

157

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

316

1525

2.13

33.34

2.3

0.62

1.05

g/l

1.49

280

1280

(3027945) Reticulocytes/100 erythrocytes in Blood

809

5239

1.62

32.95

2.5

2.4

1.80

0.01

731

4611

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

298

1415

2.16

32.77

2.1

38.29

37.60

g/l

1.20

256

1216

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

238

1035

2.35

32.34

1.3

1.2

1.18

5.45

u/ml

1.38

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

282

1330

2.17

31.55

2.3

2.2

0.01

0.03

g/l

0.66

263

1202

(3017143) Hepatitis C virus Ab [Presence] in Serum

744

4771

1.63

31.45

1.6

1.5

—

(3045414) Leukocytes [Presence] in Urine

411

2224

1.91

31.43

2.0

1.9

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

263

1212

2.22

31.16

1.2

1.1

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

671

4224

1.66

30.47

3.8

3.4

5.85

5.80

kpa

0.66

653

4103

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

669

4211

1.66

30.39

2.8

2.7

157.12

197.36

ng/l

2.08

602

3837

(3002032) Base excess in Venous blood by calculation

668

4216

1.65

30.01

3.8

3.4

1.97

2.03

mmol/l

0.15

582

3587

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

385

2074

1.91

29.83

3.7

3.8

24.31

24.28

mmol/l

0.07

376

2029

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

437

2467

1.83

29.22

1.1

1.0

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

517

3075

1.74

28.95

2.0

1.7

—

(3025941) Bacteria identified in Stool by Culture

467

2701

1.79

28.81

1.4

1.2

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

435

2466

1.82

28.69

1.4

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

961

6679

1.52

28.40

8.0

6.5

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

472

2755

1.77

28.21

1.6

1.4

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

646

4106

1.64

28.15

2.5

2.6

67.54

64.69

ml/min/173m2

1.06

276

1602

(3003458) Phosphate [Moles/volume] in Serum or Plasma

912

6287

1.52

27.97

5.1

1.04

mmol/l

0.30

840

5809

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

568

3503

1.68

27.82

2.1

1.8

—

(3019060) Gas panel - Arterial blood

500

2986

1.73

27.56

4.1

4.9

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

259

1248

2.12

27.44

2.3

2.2

0.00

g/l

-0.00

240

1128

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

257

1235

2.13

27.42

2.3

2.2

0.00

g/l

-0.00

240

1126

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

350

1886

1.90

27.08

1.7

1.6

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

281

1412

2.03

26.61

2.3

2.1

284.69

696.74

ug/l

1.82

262

1309

(3005719) IgG [Mass/volume] in Serum or Plasma

566

3532

1.66

26.46

2.8

2.9

10.04

10.59

g/l

2.54

514

3246

(3008152) Bicarbonate [Moles/volume] in Arterial blood

480

2867

1.73

26.43

6.5

6.9

24.72

24.75

mmol/l

0.06

463

2722

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

461

2735

1.74

25.99

2.6

2.4

—

(3024354) Oxygen [Partial pressure] in Venous blood

553

3459

1.65

25.60

3.3

2.8

4.65

4.58

kpa

0.26

538

3345

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

788

5371

1.53

25.31

3.4

4.3

243.99

247.14

u/l

0.11

727

5078

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1470

11287

1.39

25.20

1.7

1.6

72891519.37

22729697.51

pmol/l

1.53

1221

9204

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

315

1684

1.92

24.96

1.7

1.6

—

(3020961) Endomysium IgA Ab [Titer] in Serum

390

2231

1.80

24.92

1.1

88.75

175.89

titre

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

260

1302

2.04

24.87

1.4

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

359

2047

1.80

23.19

1.9

2.0

39.90

39.23

u/l

0.23

313

1805

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

411

2439

1.73

23.12

7.6

8.7

24.57

24.50

mmol/l

0.17

391

2367

(4034850) Laboratory test

311

1698

1.87

23.11

11.6

8.8

—

(3026389) Candida sp identified in Specimen by Organism specific culture

178

792

2.28

23.01

1.6

1.4

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

730

5010

1.52

22.57

1.7

1.6

1.46

1.41

1.36

642

4392

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

160

688

2.36

22.39

1.2

1.5

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

151

634

2.41

22.29

1.3

54.33

59.91

u/ml

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

927

6690

1.45

22.25

1.8

1.7

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

100

342

2.95

22.14

1.2

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

100

342

2.95

22.14

1.2

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

100

342

2.95

22.14

1.2

1.1

—

(3041096) Erythrocytes [Presence] in Urine by Automated

1709

13674

1.34

22.03

4.3

3.2

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

342

2.92

21.54

1.2

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

342

2.92

21.54

1.2

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

342

2.92

21.54

1.2

1.1

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

202

972

2.11

21.53

1.4

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

202

972

2.11

21.53

1.4

1.3

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

554

3631

1.57

21.06

3.0

3.4

4.39

4.44

pmol/l

0.64

487

3225

(3004616) Nuclear Ab [Presence] in Serum

136

561

2.45

20.89

1.4

1.2

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

277

1516

1.86

20.44

1.5

1.6

129.33

379.06

titre

2.23

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

397

2415

1.69

20.38

8.2

9.8

—

(3052851) Hemolysis interference index of Serum or Plasma

273

1490

1.87

20.32

2.9

3.1

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

782

5566

1.46

20.06

1.6

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

161

730

2.24

19.95

1.4

31.38

35.80

u/l

0.87

128

595

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

113

437

2.61

19.88

1.6

1.5

53.68

55.32

0.15

264

(3028026) IgM [Mass/volume] in Serum or Plasma

446

2820

1.62

19.69

1.8

1.9

1.39

1.43

g/l

0.13

404

2564

(3010144) Erythrocytes [#/volume] in Synovial fluid

327

2.87

19.64

1.2

1.4

189414.09

118581.85

e6/l

0.30

221

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

156

712

2.22

19.04

1.1

11.30

15.52

au/ml

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

437

2773

1.62

19.00

3.1

2.9

128.58

127.03

g/l

0.82

428

2710

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

239

1285

1.89

18.66

2.0

10.91

11.10

mg/l

0.15

219

1195

(3020891) Body temperature

316

1865

1.73

18.13

4.8

4.2

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

809

5904

1.42

18.03

1.5

—

(3023511) Choriogonadotropin [Units/volume] in Urine

136

600

2.29

18.02

1.4

1.2

—

(3024928) Oxygen saturation in Venous blood

181

899

2.04

17.79

2.3

2.8

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

356

2190

1.66

17.51

1.9

1.7

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

551

3759

1.51

17.38

1.2

141.53

145.14

iu/ml

0.07

224

1492

(3020779) Urea [Moles/volume] in Serum or Plasma

581

4012

1.49

17.28

6.7

6.6

9.22

9.54

mmol/l

0.56

549

3810

(3018405) Lactate [Moles/volume] in Arterial blood

280

1620

1.76

17.24

4.0

3.7

1.33

1.35

mmol/l

0.10

275

1591

(3019230) Fractional oxyhemoglobin in Venous blood

152

724

2.13

16.72

2.0

2.5

58.43

63.79

2.11

152

718

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

186

968

1.95

16.06

1.2

3.78

3.76

mmol/l

0.11

171

915

(3025159) Blasts/100 leukocytes in Blood

547

3788

1.48

16.01

4.3

3.9

0.10

0.59

1.86

145

1017

(3013512) EKG study

1843

15454

1.27

15.64

4.3

3.6

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

193

1027

1.91

15.60

1.4

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

227

1276

1.81

15.44

3.0

2.3

188.44

193.25

0.33

213

1214

(3036489) Thrombin time

284

1710

1.69

15.18

2.2

1.9

20.69

21.48

2.45

252

1505

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

6.27

14.99

1.0

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

402

2.43

14.87

1.6

1.7

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

246

1436

1.74

14.72

1.9

1.7

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

117

529

2.23

14.70

1.4

1.5

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

404

2673

1.55

14.68

3.8

3.4

5.18

5.17

kpa

0.19

386

2531

(3014051) Protein [Presence] in Urine by Test strip

226

1295

1.77

14.43

2.7

2.5

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

133

638

2.11

14.42

1.3

1.2

2.59

3.81

u/ml

1.82

262

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

202

1121

1.83

14.35

1.3

461.47

541.13

mg/l

2.02

195

1067

(3049717) Cytology report of Urine Cyto stain

252

1492

1.72

14.34

2.4

2.6

—

(40768443) Skin Pathology biopsy report

362

2351

1.57

14.28

1.3

1.2

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

282

2.68

14.07

1.4

1.3

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

347

2.50

13.99

1.6

1.4

32.99

34.32

0.10

194

(3034860) Kappa light chains.free [Mass/volume] in Serum

254

1520

1.70

13.91

2.9

3.5

36.79

49.04

mg/l

2.38

215

1192

(3030981) Hyaline casts [#/volume] in Urine by Automated count

370

2431

1.55

13.87

2.9

2.4

0.20

0.33

e6/l

2.10

355

2357

(3009343) pH of Capillary blood

395

2635

1.53

13.83

3.8

3.4

7.42

0.17

370

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

181

3.11

13.82

1.1

—

(3017181) Myelocytes/100 leukocytes in Blood

582

4196

1.43

13.75

4.3

3.9

0.92

0.99

0.21

182

1405

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

253

1519

1.69

13.69

2.9

3.5

28.37

56.67

mg/l

2.38

214

1197

(3023420) DNA double strand Ab [Units/volume] in Serum

112

513

2.20

13.67

1.5

1.6

—

30.97

—

(3021440) Promyelocytes/100 leukocytes in Blood

556

3994

1.43

13.40

4.3

3.9

0.10

0.12

0.21

154

1212

(3021879) Hepatitis B virus core Ab [Presence] in Serum

449

3098

1.48

13.37

1.3

1.4

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

380

2535

1.53

13.30

3.8

3.4

1.81

2.05

mmol/l

0.69

289

1912

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

179

983

1.84

13.18

1.2

1.4

14.02

42.51

e6/l

1.33

133

748

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

131

647

2.05

13.18

1.1

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

281

2.62

13.10

1.4

1.3

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

179

985

1.84

13.10

1.3

1.4

832.87

1104.03

e6/l

0.23

142

797

(3045424) Erythrocytes [Presence] in Urine

160

854

1.90

12.89

1.7

1.5

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1349

11120

1.27

12.77

1.5

1.4

—

(4094501) Cardiovascular stress test using bicycle ergometer

222

1314

1.71

12.69

1.1

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

243

1474

1.67

12.68

2.8

3.4

1.27

1.42

ratio

0.36

100

(3024980) IgG subclass 4 [Mass/volume] in Serum

138

705

1.98

12.66

1.6

0.64

0.76

g/l

0.74

111

520

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

310

1999

1.58

12.64

1.6

1.5

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

231

1386

1.69

12.56

1.3

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

213

1254

1.72

12.42

1.7

336.78

321.29

mu/l

0.14

189

1135

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

320

2.46

12.30

1.4

1.3

0.42

1.39

u/ml

1.25

177

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

144

756

1.93

12.21

1.8

1.6

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

139

722

1.95

12.17

1.2

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

146

772

1.91

12.12

1.1

0.98

2.15

u/ml

1.40

370

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

221

1324

1.69

12.10

1.4

1.3

192.33

228.77

miu/ml

0.86

100

640

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

130

662

1.98

12.05

1.3

1.2

1.73

3.87

u/ml

2.36

221

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

314

2058

1.55

11.93

1.8

1.7

1.57

1.59

g/l

0.13

274

1740

(3017315) Amylase [Enzymatic activity/volume] in Urine

231

2.70

11.90

1.6

1.2

568.30

276.09

u/l

0.32

215

(3027135) IgG subclass 1 [Mass/volume] in Serum

438

2.21

11.89

1.5

1.4

5.87

6.99

g/l

2.77

305

(3024139) IgG subclass 3 [Mass/volume] in Serum

438

2.21

11.89

1.5

1.4

0.45

0.41

g/l

0.47

304

(3028192) IgG subclass 2 [Mass/volume] in Serum

438

2.21

11.89

1.5

1.4

2.87

2.81

g/l

0.12

305

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

100

464

2.17

11.88

1.2

1.1

98.10

93.90

0.93

438

(3017732) Neutrophils [#/volume] in Blood

488

3510

1.42

11.67

3.3

2.9

5.38

5.17

e9/l

0.09

368

2793

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

138

730

1.91

11.47

1.2

1.3

6.66

2.25

nmol/l

0.32

132

693

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

138

733

1.90

11.33

1.2

1.3

0.29

nmol/l

0.01

(3047181) Lactate [Moles/volume] in Blood

233

1442

1.64

11.28

4.4

6.3

1.21

1.31

mmol/l

1.46

210

1281

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

221

2.69

11.23

1.5

1.6

—

(4062490) Immunoglobulin typing, IgG

438

2.16

11.08

1.6

1.4

—

(3011648) Oxygen content in Venous blood

330

2.35

11.07

1.7

1.9

10.03

11.12

1.32

330

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

432

2.17

11.05

2.5

2.2

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

204

1227

1.68

11.04

1.6

1.4

15.86

18.63

iu/ml

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

289

2.44

10.93

1.2

1.1

38.29

41.93

mg/l

0.20

238

(3003888) Timothy IgE Ab [Units/volume] in Serum

131

693

1.91

10.91

1.1

3.91

4.12

u/ml

0.06

318

(3024891) Influenza virus A+B Ag [Presence] in Specimen

202

1216

1.68

10.90

1.2

1.1

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

436

2.15

10.80

1.1

—

3.84

—

(3002179) Metamyelocytes/100 leukocytes in Blood

520

3832

1.39

10.80

4.1

3.8

0.68

0.77

0.38

161

1206

(3011288) Drugs identified in Urine by Screen method

132

703

1.90

10.77

2.6

2.4

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

279

2.45

10.77

1.1

234.57

257.41

mg/l

0.46

239

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

176

2.86

10.71

2.3

1.5

145.31

157.57

umol/l

0.09

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

139

3.11

10.68

1.0

1.3

—

(1002224) Polysomnography panel

281

1846

1.55

10.60

1.1

—

(3003181) Sodium [Moles/volume] in Urine

161

919

1.77

10.52

1.4

59.50

62.82

mmol/l

0.63

140

725

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

302

2.37

10.41

1.4

2.2

16.65

17.50

nmol/l

0.36

283

(3024263) Appearance of Synovial fluid

190

2.75

10.41

1.3

1.4

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

316

4566

0.68

10.29

1.7

1.8

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

220

1382

1.61

10.07

2.4

2.0

98.07

92.52

3.31

208

1325

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

120

634

1.91

10.06

2.3

2.0

20.62

27.54

mg/l

0.84

157

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

118

620

1.92

10.06

1.2

1.1

130.15

120.31

2.15

108

555

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

115

601

1.93

9.97

1.5

1.4

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

248

1607

1.56

9.96

4.3

3.8

25.00

25.08

mmol/l

0.19

221

1481

(44813793) Dust mix specific IgE antibody measurement

334

2.26

9.91

1.1

—

(3022621) pH of Urine by Test strip

461

3378

1.39

9.91

3.5

3.0

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

238

1531

1.58

9.87

2.6

2.7

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

121

646

1.89

9.84

1.2

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

123

662

1.87

9.76

1.1

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

449

2.06

9.68

3.8

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

153

2.89

9.67

1.3

1.2

0.29

0.31

g/l

0.50

117

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

263

2.41

9.66

1.1

0.94

11.54

nmol/l

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

683

5335

1.31

9.65

4.5

4.2

21.85

21.90

0.03

335

2623

(3044290) Cell count panel - Cerebral spinal fluid

159

928

1.73

9.65

1.2

1.4

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

831

6667

1.28

9.59

5.1

4.9

1.95

3.73

ug/l

2.00

758

5894

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

125

684

1.84

9.43

1.2

1.3

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

117

627

1.88

9.43

1.1

0.39

1.55

u/ml

3.40

280

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

208

1314

1.60

9.33

1.1

5.92

8.80

u/ml

0.42

155

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

281

1900

1.50

9.30

4.5

5.2

1.78

1.59

1.64

265

1779

(3024522) Salmonella sp identified in Specimen by Organism specific culture

112

596

1.89

9.23

1.5

—

(3007566) Smooth muscle Ab [Titer] in Serum

215

1376

1.58

9.14

1.2

116.84

193.48

titre

0.69

115

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

110

586

1.89

9.04

1.5

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

110

587

1.89

9.00

1.5

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

110

588

1.89

8.95

1.5

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

166

2.72

8.90

1.1

41.00

378.90

ng/l

1.91

(3008401) Mugwort IgE Ab [Units/volume] in Serum

121

669

1.82

8.86

1.1

0.32

1.10

u/ml

2.43

255

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

637

4992

1.31

8.78

2.1

0.23

0.21

g/l

6.50

592

4660

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

114

3.08

8.65

1.0

1.3

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

142

833

1.72

8.52

1.1

1.2

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

347

2490

1.42

8.45

1.3

30.22

36.29

iu/l

2.84

296

2158

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

115

636

1.82

8.44

1.2

1.3

—

nmol/l

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

193

1231

1.59

8.36

1.2

1.3

—

(3028707) Methadone [Presence] in Urine by Screen method

468

1.96

8.34

2.7

2.3

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

272

1872

1.47

8.29

4.4

5.3

0.89

0.04

257

1752

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

276

2.26

8.27

1.0

1.1

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

227

1506

1.53

8.26

1.8

1.9

42.57

10.41

iu/l

0.37

558

(3034891) Synovial lining cells/100 cells in Synovial fluid

185

2.55

8.21

1.7

1.4

4.29

2.89

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

108

591

1.84

8.21

1.5

1.4

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

528

1.89

8.15

1.0

1.1

1.60

3.26

u/ml

1.20

182

(3022313) Gas panel - Capillary blood

272

1880

1.47

8.12

4.1

3.6

—

(3018572) Chloride [Moles/volume] in Blood

164

1017

1.63

8.00

5.0

7.4

104.59

105.25

mmol/l

0.96

152

911

(3039000) Anion gap in Blood

164

1017

1.63

8.00

5.0

7.4

10.89

11.15

mmol/l

0.53

152

911

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

180

1144

1.59

7.94

2.1

1.9

6451.68

4240.43

u/l

0.27

454

(40760888) Immunoglobulin light chains.free panel - Serum

180

1145

1.59

7.91

3.0

3.8

—

(21494755) Public health laboratory ask at order entry panel

336

4584

0.72

7.90

1.3

1.4

—

(3011985) Renin [Units/volume] in Plasma

117

667

1.77

7.79

1.5

51.19

49.47

mu/l

0.05

104

595

(3023419) Bacteria identified in Sputum by Culture

119

682

1.76

7.79

2.8

2.4

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

111

625

1.79

7.71

1.3

290.19

297.35

pmol/l

0.09

102

553

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

371

2.03

7.69

1.3

1.2

97.33

69.24

u/ml

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

371

2.03

7.69

1.3

1.2

21.20

45.52

u/ml

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

147

896

1.66

7.69

1.2

—

(1761868) Lipid panel - Serum or Plasma

1704

19185

0.85

7.59

3.0

2.8

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

130

770

1.70

7.58

1.1

—

(3019225) pH of Specimen

666

5350

1.27

7.56

5.2

4.0

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

257

1783

1.46

7.55

2.1

1.9

0.87

2.37

ug/l

4.13

216

1569

(3032057) Clostridioides difficile [Presence] in Stool

3.07

7.41

2.0

1.9

—

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

8.35

7.30

1.1

1.0

0.24

0.09

u/ml

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

226

1541

1.48

7.26

2.5

2.9

0.34

0.37

u/ml

0.63

133

895

(3002619) Bacteria identified in Specimen by Culture

3.49

7.25

1.4

1.1

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

170

1091

1.57

7.23

1.7

1.6

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

458

1.89

7.17

1.0

0.08

0.37

u/ml

0.50

114

(3016244) Insulin [Units/volume] in Serum or Plasma

242

2.24

7.15

3.0

3.6

26.74

23.47

mu/l

0.27

232

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

3.34

7.09

1.2

41.44

35.39

0.31

(3044927) Protein electrophoresis panel - Urine

446

1.90

7.07

1.4

1.2

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

316

2.07

7.02

1.1

6.89

9.18

iu/ml

0.35

(3016650) Hepatitis A virus Ab [Presence] in Serum

125

749

1.68

7.01

1.1

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

311

2266

1.39

6.98

3.8

3.0

25.46

25.26

mmol/l

0.50

300

2216

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

379

1.96

6.93

1.1

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

196

1311

1.51

6.93

2.6

2.4

3.68

3.64

g/l

0.15

186

1251

(3035320) C reactive protein [Mass/volume] in Body fluid

352

2.00

6.91

3.3

2.2

—

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

7.52

6.88

1.1

1.0

0.28

0.16

u/ml

—

(3036071) Salmonella sp Ab [Titer] in Serum

119

2.78

6.88

1.1

—

(3016018) Differential panel - Cerebral spinal fluid

508

1.82

6.87

1.2

1.4

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

125

2.73

6.84

1.0

1.1

—

(3029075) Extractable nuclear Ab panel - Serum

131

2.68

6.81

1.1

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

216

2.28

6.76

1.4

1.6

2.56

5.89

nmol/l

0.84

176

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

185

2.39

6.75

1.6

1.2

2.61

3.90

umol/l

2.72

172

(3002256) Pathology report gross observation

876

7348

1.22

6.73

1.2

1.3

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

217

3091

0.69

6.59

1.4

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

175

2.41

6.58

1.1

1.4

86.79

210.21

nmol/24h

0.70

175

(3014133) Dog dander IgE Ab [Units/volume] in Serum

100

574

1.75

6.58

1.0

1.20

3.09

u/ml

2.39

249

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

367

1.94

6.50

1.4

25.47

19.26

u/ml

0.67

(3038177) Helicobacter pylori Ab [Presence] in Serum

134

835

1.62

6.49

1.2

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

123

2.69

6.49

1.0

1.1

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

141

2.56

6.43

1.2

1.1

97.85

93.07

0.37

(3017446) Testosterone [Moles/volume] in Serum or Plasma

215

1490

1.46

6.41

2.3

2.0

11.36

11.47

nmol/l

0.06

194

1307

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

4.06

6.34

1.0

1.1

1.50

1.65

umol/24h

0.37

(3000330) Specific gravity of Urine by Test strip

348

2625

1.34

6.32

4.0

3.4

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

378

1.91

6.31

1.0

1.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

125

2.65

6.30

1.0

1.1

—

(3035637) Corticotropin [Mass/volume] in Plasma

101

590

1.72

6.27

1.4

1.5

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

192

2.30

6.24

1.1

3.43

3.67

iu/ml

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

401

1.88

6.23

1.4

1.8

6.13

8.55

umol/l

0.66

292

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

120

2.67

6.23

1.0

1.1

—

(3010838) Calcium [Moles/time] in 24 hour Urine

157

1026

1.54

6.22

1.7

1.9

4.94

5.18

mmol/24h

0.43

143

893

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

532

1.76

6.21

6.8

6.2

12.24

12.07

mg/l

0.12

492

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

120

736

1.64

6.21

1.5

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

120

736

1.64

6.21

1.5

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

312

2.00

6.15

1.3

1.2

26.00

71.03

titre

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

320

1.98

6.09

1.3

1.2

310.00

206.52

titre

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

3.59

6.03

1.0

1.1

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

140

2.51

6.01

1.3

1.1

97.70

92.91

0.28

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

378

1.89

5.99

1.2

1.3

1.66

1.48

nmol/l

0.61

346

(3033923) Metanephrine [Moles/time] in 24 hour Urine

101

2.78

5.88

1.1

0.60

0.65

umol/24h

0.32

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

191

2.26

5.88

1.5

1.1

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

417

1.83

5.85

1.2

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

218

2.16

5.79

1.0

1.1

1.05

1.16

u/l

1.10

109

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

155

2.40

5.77

1.1

—

(3006653) Thiamine [Moles/volume] in Blood

213

2.17

5.70

1.3

136.93

136.17

nmol/l

0.04

213

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

144

2.44

5.68

1.3

1.1

112.17

109.22

0.20

129

(3008295) Osmolality of Serum or Plasma

495

1.75

5.66

1.2

1.4

273.55

275.71

mosm/kgh2o

0.41

379

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

3.19

5.58

1.7

1.8

13.88

17.74

umol/l

0.94

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

3.40

5.57

1.0

1.1

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

505

1.73

5.57

1.5

1.7

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

129

829

1.57

5.55

2.4

1.7

—

(3006270) Folate [Moles/volume] in Blood

417

1.81

5.55

1.4

1.1

358.75

357.68

nmol/l

0.02

354

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

589

1.67

5.53

1.2

47.81

60.27

u/l

2.51

534

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

339

1.90

5.52

1.1

1.2

83.09

81.50

u/l

0.07

303

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

128

2.51

5.52

1.0

1.1

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

332

1.91

5.51

1.1

1.2

21.30

20.44

u/l

0.08

287

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

154

1037

1.50

5.37

2.1

2.7

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

157

1063

1.49

5.33

2.4

2.1

131.30

128.60

g/l

0.87

114

738

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

460

1.75

5.31

1.2

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

106

658

1.62

5.29

4.8

5.3

354.84

380.18

umol/l

1.02

575

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

108

676

1.61

5.22

1.2

1.1

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

228

2.07

5.21

1.4

1.3

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

176

2.22

5.17

3.1

2.4

—

(3016038) Potassium [Moles/volume] in Urine

340

1.86

5.16

1.3

1.2

36.09

34.69

mmol/l

0.17

286

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

183

1289

1.43

5.09

1.8

1.6

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

2.77

5.03

1.2

1.3

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

268

2016

1.34

5.02

2.2

1.9

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

152

1036

1.48

5.02

2.3

139.38

60.74

ug/min

0.97

605

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

153

2.29

5.01

1.5

0.39

0.40

ug/l

0.03

(3000034) Microalbumin [Mass/volume] in Urine

440

1.74

4.95

3.1

2.9

62.11

17.05

mg/l

0.74

311

(3037756) Immunofixation for Serum or Plasma

149

1015

1.48

4.94

1.9

1.8

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

471

1.71

4.92

1.5

1.7

—

(3014271) Vancomycin [Susceptibility]

236

2.00

4.78

3.8

2.8

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

169

1190

1.43

4.73

1.3

1.2

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

130

870

1.50

4.72

1.2

1.3

13.15

15.28

u/l

0.87

101

702

(3025018) Bordetella pertussis Ab [Titer] in Serum

288

1.88

4.62

1.2

—

(3023410) Appearance of Cerebral spinal fluid

450

1.70

4.60

1.3

1.5

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

450

1.70

4.60

1.3

1.6

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

496

1.66

4.59

1.5

1.4

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

496

1.66

4.59

1.5

1.4

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

244

1838

1.34

4.57

2.1

1.7

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

206

2.05

4.56

1.2

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

564

1.60

4.39

1.1

—

(3036180) Methadone [Presence] in Urine

125

2.33

4.33

1.4

1.6

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

499

1.63

4.25

3.7

3.9

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

123

834

1.48

4.23

2.0

1.6

—

(3015183) Erythrocyte sedimentation rate

206

2.00

4.20

1.1

1.3

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

455

1.66

4.18

3.3

2.9

—

(3020874) Milk IgE Ab [Units/volume] in Serum

270

1.86

4.16

1.0

0.38

2.72

u/ml

0.99

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

2.59

4.13

1.6

1.1

122.33

74.35

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

2.56

4.04

1.5

1.1

100.17

82.53

—

(3019832) Treponema pallidum Ab [Presence] in Serum

367

2969

1.25

4.02

1.6

1.5

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

176

2.05

3.99

3.2

2.9

24.54

28.12

umol/l

1.13

127

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

1261

0.64

3.99

1.4

1.5

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

619

5286

1.19

3.95

3.5

3.2

—

(3000093) Morphology [Interpretation] in Blood Narrative

402

1.67

3.92

1.1

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

240

1.88

3.91

1.3

1.2

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

153

1099

1.40

3.90

1.7

1.5

—

(3036670) Protein [Mass/volume] in Synovial fluid

106

2.36

3.89

1.6

1.2

35.46

36.45

g/l

0.13

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

535

1.58

3.88

1.0

—

(3016879) Cocaine [Presence] in Urine

142

1009

1.42

3.86

2.3

1.8

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

278

1.80

3.82

1.1

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

459

1.62

3.82

3.6

3.5

58.87

57.51

0.22

386

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

407

1.65

3.76

1.4

1.6

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

407

1.65

3.76

1.4

1.6

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

407

1.65

3.76

1.4

1.6

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

140

2.15

3.76

1.6

2.0

—

(3000764) Benzodiazepines [Presence] in Urine

154

1116

1.39

3.75

2.2

1.7

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

464

3878

1.21

3.75

3.0

0.60

0.82

ug/l

7.51

328

2579

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

347

1.71

3.73

1.8

1.7

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

110

751

1.47

3.71

1.4

124.31

119.85

u/ml

0.10

146

(3012494) Peanut IgE Ab [Units/volume] in Serum

115

2.27

3.70

1.0

1.1

1.59

1.51

u/ml

0.02

(3020191) Ethanol [Moles/volume] in Serum or Plasma

274

1.79

3.69

1.6

1.4

1.30

1.20

promille

0.19

199

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

2.61

3.63

1.0

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

2.54

3.62

1.2

1.3

0.96

57.18

mg/l

0.49

(3030313) Adrenal Ab [Titer] in Serum

4.41

3.62

1.0

1.1

—

(3028300) Cannabinoids [Presence] in Urine

154

1125

1.38

3.59

2.2

1.7

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

452

1.60

3.56

1.1

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

214

1.87

3.48

1.0

1.1

3.41

8.20

u/ml

0.98

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

273

1.76

3.44

1.0

1.1

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

114

797

1.44

3.43

1.6

1.4

—

(3002079) Sodium [Moles/time] in 24 hour Urine

208

1.88

3.43

1.3

1.2

175.19

144.50

mmol/24h

0.82

208

(3009871) Measles virus Ab [Titer] in Serum

167

1.98

3.38

1.6

1.8

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

2.44

3.37

1.1

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

188

1.92

3.37

1.1

2082.36

1385.47

miu/ml

2.23

188

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

678

1.47

3.33

1.6

1.4

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

108

2.23

3.31

1.2

1.1

—

(1616796) Gas panel - Central venous blood

136

988

1.38

3.31

3.7

3.4

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

117

831

1.42

3.25

1.4

1.3

—

(3027008) Opiates [Presence] in Urine

151

1120

1.36

3.24

2.3

1.7

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

249

1.77

3.23

1.1

1.2

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

650

1.47

3.22

1.1

2.38

3.19

u/ml

0.46

300

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

2.39

3.22

1.3

1.4

—

(4035726) Immunohistochemistry procedure

479

5604

0.84

3.22

1.3

1.4

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

103

717

1.44

3.20

1.2

23.20

38.47

u/l

1.45

617

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

250

1.77

3.19

1.0

1.1

—

(3021901) Oxygen saturation in Capillary blood

113

801

1.42

3.18

2.8

2.6

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

221

1.81

3.18

1.4

1.5

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

221

1.81

3.18

1.4

1.5

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

145

1073

1.36

3.16

1.7

1.6

—

(3027944) Amphetamines [Presence] in Urine

149

1109

1.35

3.14

2.2

1.7

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

124

2.10

3.13

1.0

5.09

13.46

u/ml

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

2.63

3.13

1.2

1.3

42.43

56.76

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

754

0.59

3.11

1.4

1.5

—

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

3.67

3.08

1.2

1.3

56.00

41.55

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

4.00

3.08

1.3

1.1

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

7.51

3.05

1.0

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

424

1.56

3.02

1.3

1.2

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

347

1.62

2.98

1.3

1.4

1.95

2.13

mmol/l

1.33

322

(3051611) Lipemic interference index of Serum or Plasma

571

1.48

2.97

3.0

3.1

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

101

2.18

2.92

2.5

2.2

17.16

120.01

au/ml

—

(3020876) Protein [Mass/time] in 24 hour Urine

484

1.51

2.92

2.3

2.5

1.07

1.26

g/24h

0.29

221

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

258

1.71

2.89

1.0

1.1

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

4.10

2.88

1.0

1.3

—

(3042517) Benzodiazepines panel - Urine

4.10

2.88

1.1

1.5

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

306

1.64

2.81

1.3

1.4

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

369

1.58

2.79

1.6

4.71

5.98

u/l

0.48

314

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

131

1.99

2.74

1.1

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

131

1.99

2.74

1.0

—

(3034426) Prothrombin time (PT)

138

1.96

2.74

1.3

1.2

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

270

1.67

2.74

1.0

0.32

0.71

u/ml

0.83

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

255

1.69

2.73

1.2

1.3

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

125

928

1.35

2.72

1.8

1.7

0.91

0.79

nmol/l

1.09

104

783

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

317

1.61

2.71

1.3

1.4

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

196

1.79

2.71

2.8

2.3

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

2.18

2.66

1.5

1.3

152.56

87.15

ng/l

0.48

(21494890) Protein electrophoresis panel - 24 hour Urine

471

1.49

2.64

1.8

2.2

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

714

1.39

2.59

2.6

2.4

240.40

2926.78

u/ml

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

4.67

2.59

1.0

—

(44786800) Granulocytes/100 leukocytes in Body fluid

0.00

2.56

0.0

1.3

—

21.36

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

362

1.55

2.55

1.5

1.7

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

123

925

1.34

2.49

4.9

408.78

763.42

iu/ml

0.39

133

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

284

0.42

2.45

1.1

1.2

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

460

4000

1.16

2.44

1.4

1.3

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

2.55

2.44

1.1

1.0

0.03

0.05

u/ml

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

2.50

2.35

1.2

1.1

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

229

1.66

2.32

1.5

1.4

1.18

1.30

nmol/l

0.22

171

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

697

0.64

2.32

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

696

0.64

2.30

1.4

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

119

1.94

2.29

1.1

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

694

0.65

2.28

1.4

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

185

1.73

2.27

1.1

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

693

0.65

2.26

1.4

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

445

0.56

2.26

1.2

1.5

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

104

777

1.34

2.24

1.3

1.2

296.94

280.78

u/ml

0.12

475

(3043238) Trisomy 21 risk [Likelihood] in Fetus

606

0.62

2.24

1.4

1.5

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

2.50

2.18

1.2

1.4

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

534

1.41

2.17

1.1

—

(3025577) Chromium [Mass/volume] in Blood

289

1.56

2.16

2.1

3.01

2.70

ug/l

0.23

244

(3047352) Trisomy 18 risk [Likelihood] in Fetus

587

0.63

2.14

1.4

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

2.10

2.12

1.3

1.4

—

(3013637) Mi-2 Ab [Presence] in Serum

2.05

2.11

1.1

1.0

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

2.05

2.11

1.1

1.0

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

2.05

2.11

1.1

1.0

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

2.05

2.11

1.1

1.0

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

3.20

2.09

1.0

1.1

6.38

19.00

u/l

—

(3005033) Fetal Nuchal fold Thickness US

583

0.63

2.09

1.4

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

109

832

1.32

2.06

1.2

—

(3040151) Glucose [Moles/volume] in Capillary blood

532

1.40

2.05

5.5

5.1

6.96

7.36

mmol/l

0.56

445

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

2.32

2.04

1.0

1.1

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

601

1.37

2.03

1.6

1.4

—

(3003694) ABO and Rh group [Type] in Blood

1488

13992

1.08

1.95

1.4

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

270

0.48

1.95

1.2

1.3

—

(3008536) Aspergillus sp Ab [Presence] in Serum

1.98

1.94

1.2

2.1

—

(3019174) dRVVT (LA screen)

2.57

1.94

1.1

1.2

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

2.97

1.93

1.1

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

513

4578

1.13

1.92

3.1

3.6

1.24

mmol/l

0.49

458

3920

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

142

1.76

1.92

1.9

1.6

8.22

8.72

ug/l

0.38

142

(3037121) Protein [Mass/volume] in Urine

196

1623

1.21

1.89

3.1

0.26

0.25

g/l

0.08

623

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

243

1.57

1.89

1.4

1.8

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

243

1.57

1.89

1.1

1.0

0.72

0.28

u/ml

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

243

1.57

1.89

1.4

1.8

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

106

818

1.30

1.88

1.8

1.6

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

3.18

1.88

1.0

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

2.39

1.85

1.0

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

1.98

1.84

1.1

1.0

0.49

1.16

u/ml

0.50

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

638

1.34

1.83

1.6

1.4

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

527

1.37

1.82

3.7

5.3

221.86

119.83

u/ml

0.23

163

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

262

1.53

1.80

1.3

1.6

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

166

0.42

1.78

1.9

1.5

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

192

1.62

1.77

1.5

1.9

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

169

1.66

1.76

3.0

2.7

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

3.34

1.74

1.0

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.22

1.73

1.2

1.1

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

3.85

1.71

1.2

1.0

—

(4281824) Cell count and differential, peritoneal fluid

956

0.75

1.66

1.0

1.1

—

(3005011) Chlamydia sp Ab [Titer] in Serum

2.10

1.65

1.9

1.7

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

189

1.59

1.62

1.5

1.9

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

189

1.59

1.62

1.5

1.9

—

(40768446) Kidney Pathology biopsy report

158

1.65

1.61

1.9

1.6

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

207

1.55

1.56

5.5

4.4

—

(3010421) pH of Blood

149

1229

1.22

1.55

3.6

3.7

7.43

7.42

0.66

140

1114

(3006462) Nitrate [Presence] in Urine

248

1.49

1.54

4.9

3.1

—

(3043410) Blood group antigens tested for on Red Blood Cells

122

1.72

1.54

1.9

1.4

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

122

1.72

1.54

4.5

3.0

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

122

1.72

1.54

4.5

3.0

—

(3050129) First trimester maternal screen panel - Serum or Plasma

853

0.75

1.53

1.4

—

(3020491) Glucose [Moles/volume] in Blood

323

1.43

1.52

2.2

2.0

7.42

6.79

mmol/l

0.71

219

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

274

1.46

1.51

1.2

1.1

1.03

1.07

ratio

1.17

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

704

1.28

1.50

1.3

1.4

0.29

0.35

nmol/l

0.43

538

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

130

1063

1.23

1.49

1.4

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

607

0.71

1.49

1.4

1.5

—

(3004809) Band form neutrophils/100 leukocytes in Blood

785

1.27

1.48

3.5

3.3

0.87

1.58

3.22

698

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

469

4238

1.11

1.48

2.6

3.8

90.76

61.41

u/ml

0.33

447

4081

(40767503) Oxygen content in Capillary blood by calculation

121

983

1.24

1.47

2.9

2.4

16.71

16.17

1.14

491

(3006442) Creatine [Moles/volume] in Serum or Plasma

285

1.44

2.3

1.5

73.05

79.71

umol/l

1.26

285

(3008402) Methanol [Moles/volume] in Serum or Plasma

2.31

1.42

1.0

1.2

—

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

2.31

1.42

1.0

1.2

—

(3017704) Immunofixation for Urine

253

1.47

1.42

1.4

1.9

—

(3025130) Human papilloma virus identified in Specimen

109

880

1.24

1.42

1.6

1.7

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

238

1.47

1.39

1.1

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

134

1.64

1.38

1.0

1.2

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

2.00

1.38

1.7

—

(3000012) Reticulocyte production index

643

1.28

1.37

1.7

2.2

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

341

1.38

1.33

1.1

307.77

293.37

mg/l

0.88

308

(40761539) Cells [Type] in Urine sediment by Light microscopy

114

1.67

1.28

1.2

1.1

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

210

1.48

1.27

1.2

1.1

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

232

2030

1.15

1.26

2.9

3.5

99.71

1633.84

u/ml

2.41

195

1720

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

211

1.47

1.24

2.1

2.0

181.67

133.04

ug/min

—

(3010937) Rubella virus Ab [Presence] in Serum

2.40

1.24

1.2

1.1

—

(3042631) Mycobacterium sp identified in Specimen

645

1.26

1.22

3.2

2.9

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

108

1.67

1.22

1.1

1.2

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

2.16

1.21

2.6

2.2

—

(3051651) Icteric interference index of Serum or Plasma

314

1.37

1.20

3.6

3.5

—

(3000285) Sodium [Moles/volume] in Blood

1.83

1.19

1.1

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

1.75

1.18

1.1

1.4

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

2.31

1.18

1.0

—

(3044009) aPTT.lupus sensitive (LA screen)

2.05

1.15

1.3

1.2

—

(3027315) Oxygen [Partial pressure] in Blood

125

1051

1.19

1.14

3.8

8.64

8.55

kpa

0.21

125

1025

(3012501) Base excess in Blood by calculation

124

1042

1.19

1.14

3.8

2.68

2.67

mmol/l

0.02

717

(3045683) HLA typing for celiac disease panel - Blood or Tissue

292

1.37

1.13

1.0

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

179

1553

1.16

1.13

1.3

—

(3019897) Erythrocyte distribution width [Ratio] by Automated count

617

1.25

1.12

3.8

2.6

13.14

13.24

0.57

609

(3013290) Carbon dioxide [Partial pressure] in Blood

124

1044

1.19

1.12

3.8

4.97

5.01

kpa

0.28

124

1019

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

327

1.35

1.11

1.0

334.03

368.39

ng/l

0.27

226

(3042733) HLA Ab [Presence] in Serum

119

1.60

1.11

5.3

5.2

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

328

1.34

1.10

1.0

782.26

682.48

ng/l

0.86

221

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

330

1.34

1.06

1.0

48.97

45.82

ng/l

0.13

223

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

641

1.24

1.05

1.0

1.1

1.44

1.52

g/l

1.34

581

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

262

1.38

1.05

1.2

1.3

5.88

6.06

mmol/l

0.35

245

(3023183) Ammonium ion [Moles/volume] in Plasma

109

914

1.20

1.05

2.2

2.5

32.52

33.37

umol/l

0.15

819

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

1.79

1.04

1.1

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

384

1.30

1.03

1.3

1.2

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

229

1.40

1.03

1.2

1.6

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

229

1.40

1.03

1.2

1.6

—

(3022689) Creatine [Moles/volume] in Urine

146

1.51

1.03

1.5

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

2.06

1.02

1.4

1.2

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

2.06

1.02

2.9

6.1

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

347

0.69

1.02

1.1

1.3

1.68

1.62

g/l

0.41

347

(3028433) Virus identified in Specimen by Culture

180

1.45

1.00

1.2

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

326

1.32

0.98

1.0

1.1

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

388

1.29

0.97

1.1

1.2

200.00

159.58

titre

0.15

(40768806) Pleura Pathology biopsy report

515

0.76

0.97

1.5

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

1.63

0.97

1.1

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

100

1.60

0.96

1.6

1.3

105.10

134.07

nmol/l

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

1.74

0.96

1.0

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

1.74

0.96

1.0

—

(3050794) Legionella sp Ab [Presence] in Serum

1.89

0.94

1.1

1.2

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

286

1.33

0.92

1.2

1.1

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

680

1.21

0.92

1.1

220655.00

1137.47

iu/ml

—

153

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

419

0.74

0.91

1.1

1.7

2.51

4.90

ug/l

1.04

326

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

255

1.34

0.86

1.8

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

123

1065

1.16

0.85

3.7

3.1

0.73

0.83

nmol/l

2.65

101

828

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

275

0.69

0.85

19.8

14.9

1476.63

4917.72

nmol/l

0.50

269

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

263

0.68

0.84

16.1

10.7

810.78

858.76

nmol/l

0.18

256

(3032743) Legionella sp IgG Ab [Presence] in Serum

1.94

0.84

1.0

1.1

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

1.94

0.84

1.0

1.1

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

1.78

0.84

3.3

2.1

—

(4146454) Self-monitoring of blood glucose

497

1.23

0.83

2.5

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

637

1.20

0.79

1.2

8.17

7.64

mmol/l

0.76

550

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

1.67

0.78

4.0

2.1

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

277

1.30

0.78

1.9

2.7

0.25

0.21

e9/l

0.71

244

(3035285) Chloride [Moles/volume] in Venous blood

620

1.20

0.78

3.1

2.3

106.42

105.11

mmol/l

2.54

613

(3024869) Neuronal Ab [Presence] in Serum

1.59

0.78

1.1

1.0

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

611

1.20

0.77

1.1

—

(40757373) Influenza virus identified in Isolate

0.50

0.77

2.2

1.4

—

(3039443) Prostate specific Ag panel - Serum or Plasma

383

0.76

0.77

1.4

1.6

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

649

1.19

0.76

1.8

1.5

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

613

1.19

0.75

3.1

2.3

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

1.64

0.75

1.2

1.1

72.82

89.97

ng/l

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.64

0.73

1.0

1.1

—

(1617658) Protocol used for examination of sentinel lymph nodes

698

0.83

0.71

1.0

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

117

1.45

0.71

1.2

446.27

326.44

pmol/l

0.25

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

1.75

0.71

1.0

1.1

8.27

8.16

mmol/l

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

270

2485

1.09

0.70

1.4

1.3

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

1.92

0.70

1.0

—

(3036312) Salmon IgE Ab [Units/volume] in Serum

1.92

0.70

1.0

0.02

0.07

u/ml

—

(40768795) Lymph node Pathology biopsy report

631

0.82

0.70

1.1

1.2

—

(3052592) Norovirus Ag [Presence] in Stool

101

1.49

0.70

1.1

1.3

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

135

1.41

0.68

1.1

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

1.53

0.68

1.4

—

(3041354) Potassium [Moles/volume] in Venous blood

620

1.18

0.68

3.1

2.3

4.05

4.03

mmol/l

0.09

613

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1.53

0.68

3.9

4.5

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

1.60

0.68

1.0

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

1.63

0.66

2.9

2.1

—

(3035880) pH of Pleural fluid

236

0.72

0.64

1.1

1.2

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

1.47

0.64

1.0

1.1

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

1.72

0.64

1.0

1.1

—

(40768441) Liver Pathology biopsy report

403

0.79

0.62

1.2

1.3

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

103

0.58

0.62

1.0

1.2

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

1.67

0.61

1.0

1.1

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

388

1.21

0.61

1.6

1.4

—

(40761536) Microorganisms panel - Urine sediment

469

4438

1.06

0.60

5.1

3.7

—

(3004775) Volume in Urine collected for unspecified duration

344

1.22

0.59

2.9

2.3

687.89

632.06

0.47

235

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

254

1.26

0.59

1.8

2.0

1.65

3.53

u/field

0.98

176

(3044242) Glucose [Moles/volume] in Arterial blood

219

1.28

0.58

2.0

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

211

1944

1.09

0.57

1.8

1.6

4.57

3.88

mg/l

0.40

186

1398

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

1.71

0.57

1.2

1.1

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

540

0.83

0.57

1.6

1.7

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.48

0.57

1.0

1.1

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

220

1.27

0.56

2.0

5.0

—

54.24

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

1.46

0.56

8.6

9.5

4.49

5.60

mmol/l

—

(4212803) Bone marrow aspirate examination

1.46

0.56

1.0

1.1

—

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

1.46

0.56

1.0

1.1

—

(3021162) Amylase [Enzymatic activity/volume] in Specimen

0.56

0.55

6.6

2.7

245.40

1229.45

u/l

—

(3012898) Urea [Moles/volume] in Urine

1.62

0.55

1.5

1.4

218.83

158.37

mmol/l

—

(1761482) Bacteria [#/volume] in Urine by Culture

153

1393

1.10

0.55

5.9

4.1

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

142

1.34

0.54

1.0

1.1

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

294

1.23

0.54

1.9

2.6

425.16

522.86

e6/l

1.13

249

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

147

0.68

0.53

1.1

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.45

0.53

2.3

3.3

0.22

0.66

u/field

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

1.52

0.52

1.8

1.6

—

(3019977) pH of Arterial blood

241

1.25

0.52

4.5

3.0

7.42

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

146

0.68

0.52

1.7

1.3

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

1.39

0.50

1.3

1.1

—

(3033799) Differential panel - Peritoneal fluid

168

0.71

0.50

1.6

1.8

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

1.46

0.50

1.2

1.1

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

198

1.26

0.49

1.2

1.0

95.39

93.57

0.10

152

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

102

1.37

0.47

1.1

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.47

0.47

1.1

1.2

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

176

0.74

0.45

1.2

1.1

—

(3004451) EKG impression Narrative

219

1.23

0.45

1.3

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

1.37

0.44

1.1

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

229

1.22

0.43

1.0

1.1

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

1.43

0.42

1.1

1.2

—

(3003740) Influenza virus B Ag [Presence] in Specimen

698

1.12

0.42

1.0

1.1

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.38

0.41

1.0

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

1.52

0.41

1.0

1.1

—

(40765096) Chromosome analysis panel by Banding

150

0.73

0.41

1.0

1.1

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

0.41

0.0

1.0

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

1.43

0.39

1.8

2.0

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

1.43

0.39

6.6

6.5

—

(3029396) Erythrocyte agglutination [Presence] in Blood

1.41

0.39

1.8

2.8

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

1.39

0.38

1.0

1.2

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

1.34

0.38

1.2

1.1

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

646

6259

1.04

0.36

2.9

4.1

5.29

29.17

ug/l

3.46

490

4996

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.29

0.36

1.3

1.1

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

253

1.19

0.36

1.7

3.0

41.80

40.49

0.15

143

(3003434) Protein [Mass/volume] in Pleural fluid

640

0.89

0.36

1.4

31.79

33.79

g/l

0.53

579

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

135

0.74

0.36

1.3

152.19

157.10

pmol/l

—

135

(3002523) Influenza virus A Ag [Presence] in Specimen

697

1.11

0.36

1.0

1.1

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

1.31

0.35

3.1

2.1

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

1.40

0.35

3.5

2.7

—

(3017569) Oxygen content in Arterial blood

199

1.21

0.35

2.5

2.3

—

(3032868) Hemoglobin electrophoresis panel in Blood

1.36

0.34

1.2

1.6

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

386

1.14

0.34

5.1

6.5

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

172

1.22

0.34

4.5

4.0

60.19

1276.84

mg/l

0.50

120

(3018851) Theophylline [Moles/volume] in Serum or Plasma

1.30

0.33

2.3

1.7

53.17

43.35

umol/l

—

(3045142) Bone marrow Pathology biopsy report

539

1.11

0.33

1.2

1.3

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

165

1.21

0.31

1.1

1.0

—

(3008037) Lactate [Moles/volume] in Venous blood

116

1082

1.07

0.30

4.0

2.9

1.46

1.60

mmol/l

1.61

111

1055

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

430

0.88

0.29

2.3

2.2

3.00

2.08

u/field

0.42

160

(3012441) Differential panel - Pleural fluid

472

0.89

0.29

1.4

—

(3028717) Thiamine [Mass/volume] in Blood

1.23

0.29

1.1

1.2

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

299

1.14

0.27

1.0

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

172

0.81

0.27

1.5

2.0

—

(21494434) Karyotype in Bone marrow

413

1.11

0.27

1.1

—

(40768793) Breast Pathology biopsy report

194

1848

1.05

0.27

1.3

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

1.23

0.27

5.4

2.8

—

34.78

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

113

1.24

0.26

1.1

1.2

—

(3036782) Glucose [Moles/volume] in Pleural fluid

437

0.89

0.26

1.3

6.64

6.46

mmol/l

0.17

403

(40758292) HTLV I+II Ab panel - Serum

1.19

0.26

1.4

1.5

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

301

1.13

0.25

1.0

—

(3048879) Bone marrow aspiration report

123

1.22

0.25

1.2

2.0

—

(3011412) CD3 cells [#/volume] in Blood

444

1.10

0.25

1.8

2.4

1.20

1.15

e9/l

0.16

404

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

170

0.82

0.25

1.1

—

(3001019) Free T4 and TSH panel - Serum or Plasma

277

2873

0.96

0.24

1.7

1.8

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

133

1.20

0.24

2.6

3.2

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

190

0.84

0.23

2.3

1.9

224.89

3491.27

e6/l

—

132

(3001729) Color of Synovial fluid

1.32

0.23

1.0

1.3

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

685

6707

1.02

0.23

5.0

4.4

32.67

33.20

0.64

455

4351

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

516

1.09

0.22

2.0

1.5

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

167

0.84

0.21

2.1

1.7

1377.80

22752.35

e6/l

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

1.19

0.21

1.2

1.1

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

1.19

0.21

1.0

1.1

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.00

0.21

0.0

1.0

—

(40769427) Triglyceride [Moles/volume] in Peritoneal fluid

0.00

0.21

0.0

1.2

—

3277.65

—

(3021367) Citalopram [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.2

—

119.00

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.5

—

669.12

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.1

—

259.62

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.00

0.21

0.0

1.0

—

(3017958) Strawberry IgE Ab [Units/volume] in Serum

0.00

0.20

0.0

1.0

—

0.02

—

(3000060) B lymphocytes [#/volume] in Blood

108

1.20

0.20

1.3

2.2

1044.29

229.25

e6/l

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

1.22

0.20

1.0

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

112

0.80

0.20

1.1

—

(3016228) CD19 cells/100 cells in Blood

207

0.87

0.19

1.9

2.1

6.67

8.44

0.44

200

(3051387) C reactive protein [Mass/volume] in Capillary blood

110

1153

0.95

0.17

4.5

3.2

21.12

27.14

mg/l

1.29

732

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

1.21

0.17

3.9

2.7

—

(3013293) Extractable nuclear Ab [Presence] in Serum

1.21

0.17

2.0

1.5

—

(3047189) Immunofixation for 24 hour Urine

224

1.12

0.17

2.4

1.8

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

120

1.17

0.16

1.0

1.1

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

1.14

0.16

12.8

6.8

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

1.20

0.16

1.1

—

5.54

—

(3041806) Other cells [#/volume] in Blood by Manual count

0.78

0.15

1.7

1.4

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

0.76

0.15

1.5

1.2

—

(3051593) INR in Capillary blood by Coagulation assay

223

0.90

0.14

8.7

12.8

—

(3038515) Glucose [Moles/volume] in Venous blood

107

1027

1.04

0.14

4.2

3.0

7.45

7.69

mmol/l

0.47

102

1005

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

113

1174

0.96

0.14

1.7

3.3

313.02

689.92

u/ml

0.53

1062

(3035933) Granulocytes/100 leukocytes in Blood

107

0.84

0.13

1.3

1.9

—

(21494814) CD8 cells/100 lymphocytes in Specimen

200

0.90

0.12

1.9

2.1

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

126

1222

1.03

0.11

3.0

2.8

1.50

1.51

mg/l

0.08

111

1113

(40758047) Lysozyme [Mass/volume] in Pleural fluid

1.06

0.09

1.4

1.1

12.64

11.74

mg/l

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

1.04

0.09

1.6

2.6

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

1.04

0.09

1.0

1.1

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

237

0.93

0.09

2.7

3.2

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

439

1.05

0.08

1.1

1.2

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

0.83

0.08

2.2

1.2

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

254

1.06

0.07

2.1

1.5

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

378

0.95

0.07

2.2

1.5

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

510

0.96

0.07

1.3

1.4

25370.04

57810.61

e6/l

1.40

299

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

1.07

0.07

1.6

1.5

—

(3013727) Leukocytes other/100 leukocytes in Blood

163

0.92

0.07

2.7

3.6

62.77

55.58

1.09

154

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

148

1.08

0.06

1.3

1.4

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

426

0.96

0.06

1.1

—

(40768800) Prostate Pathology biopsy report

436

0.96

0.06

1.1

1.2

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

434

1.04

0.06

1.1

1.2

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

257

1.05

0.05

2.1

1.5

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

140

1.07

0.04

1.5

1.2

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

524

0.97

0.04

1.2

—

(3044007) Cell count panel - Peritoneal fluid

150

1.07

0.04

2.1

1.7

—

(3023199) Leukocytes [#/volume] in Pleural fluid

564

0.97

0.04

1.3

1.4

4833.91

3223.83

e6/l

0.20

408

(3020650) Glucose [Presence] in Urine

131

1.07

0.03

1.6

1.4

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

331

1.03

0.02

1.5

2.1

—

(3045788) Cell count panel - Pleural fluid

449

0.98

0.02

1.4

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

146

0.96

0.00

1.4

1.9

1.50

2.53

ug/l

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

154

1.04

0.00

1.1

—

(3024932) HLA-DR beta [Type]

128

1.02

0.00

1.2

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

145

1.03

0.00

1.7

3.2

75.65

167.65

ng/l

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

185

0.97

0.00

1.6

1.3

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

842

1.00

0.00

1.3

1.5

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

117

1.03

0.00

1.7

1.4

27.89

26.96

g/l

—

(3024471) HLA-A [Type]

133

0.98

0.00

1.0

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

283

0.99

0.00

2.1

1.5

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

129

1.01

0.00

1.3

10.78

12.93

g/l

—

102

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

0.0

1.1

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

0.86

-0.00

1.8

1.4

—

(3016816) Cytomegalovirus IgG Ab [Presence] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

(43055189) Lymphocytes [#/area] in Urine sediment by Microscopy high power field

0.00

-0.00

0.0

1.0

—

(3051101) Glucose [Moles/volume] in Cord blood

0.93

-0.00

4.2

6.0

—

(3001409) Leptospira sp IgM Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3007919) Fasciola sp Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3007463) Buprenorphine [Presence] in Urine

0.00

-0.00

0.0

2.3

—

(3009992) Blasts/100 cells in Bone marrow

0.00

-0.00

0.0

1.8

—

17.80

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

0.91

-0.00

6.0

6.9

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

0.95

-0.00

6.7

7.1

—

(3017074) Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3036005) Urine sediment comments by Light microscopy Narrative

0.00

-0.00

0.0

1.2

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

450

1.00

-0.00

2.3

2.4

—

(3025566) Toxoplasma gondii IgG Ab [Units/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3006567) Chloride [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.0

—

(3015694) Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

0.86

-0.00

1.0

1.1

—

(3003593) Leptospira sp IgG Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

0.00

-0.00

0.0

7.8

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

0.98

-0.00

1.0

1.1

—

(3027540) Rickettsia typhi Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

0.94

-0.00

6.3

7.2

—

(3022577) Toxoplasma gondii IgM Ab [Presence] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3020893) t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence

0.00

-0.00

0.0

1.0

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

0.00

-0.00

0.0

2.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint M13_TROCHANTERICBURSITIS and mortality.

Females

Parameter	HR [95% CI]	p-value
M13_TROCHANTERICBURSITIS	0.977 [0.88, 1.08]	0.657
Birth year	0.994 [0.99, 1.0]	0.126

During the follow-up period (1.1.1998 — 31.12.2019), 2785 out of 19542 females with M13_TROCHANTERICBURSITIS died.

Males

Parameter	HR [95% CI]	p-value
M13_TROCHANTERICBURSITIS	1.217 [1.05, 1.4]	0.007
Birth year	0.988 [0.98, 1.0]	0.011

During the follow-up period (1.1.1998 — 31.12.2019), 843 out of 4000 males with M13_TROCHANTERICBURSITIS died.

Mortality risk

Mortality risk for people of age

years, who have M13_TROCHANTERICBURSITIS.

N-year risk	Females	Males
1	0.092%	0.227%
5	0.608%	1.348%
10	1.436%	3.34%
15	2.668%	6.879%
20	4.671%	11.839%

Relationships between endpoints

↥

Index endpoint: M13_TROCHANTERICBURSITIS – Trochanteric bursitis

GWS hits: 2

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Trochanteric bursitis

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints